<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN""http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"><html><head><title>Patent US6485982 - Test device and method for colored particle immunoassay - Google Patents</title><script>(function(){(function(){function e(a){this.t={};this.tick=function(a,c,b){var d=void 0!=b?b:(new Date).getTime();this.t[a]=[d,c];if(void 0==b)try{window.console.timeStamp("CSI/"+a)}catch(e){}};this.tick("start",null,a)}var a;window.performance&&(a=window.performance.timing);var f=a?new e(a.responseStart):new e;window.jstiming={Timer:e,load:f};if(a){var c=a.navigationStart,d=a.responseStart;0<c&&d>=c&&(window.jstiming.srt=d-c)}if(a){var b=window.jstiming.load;0<c&&d>=c&&(b.tick("_wtsrt",void 0,c),b.tick("wtsrt_",
"_wtsrt",d),b.tick("tbsd_","wtsrt_"))}try{a=null,window.chrome&&window.chrome.csi&&(a=Math.floor(window.chrome.csi().pageT),b&&0<c&&(b.tick("_tbnd",void 0,window.chrome.csi().startE),b.tick("tbnd_","_tbnd",c))),null==a&&window.gtbExternal&&(a=window.gtbExternal.pageT()),null==a&&window.external&&(a=window.external.pageT,b&&0<c&&(b.tick("_tbnd",void 0,window.external.startE),b.tick("tbnd_","_tbnd",c))),a&&(window.jstiming.pt=a)}catch(g){}})();})();
</script><link rel="stylesheet" href="/patents/css/_8a2b04e7bf975d5171d8e4c0b6365c7a/kl_intl_patents_bundle.css" type="text/css" /><script src="/books/javascript/atb_8a2b04e7bf975d5171d8e4c0b6365c7a__en.js"></script><script>function googleTranslateElementInit() {new google.translate.TranslateElement({pageLanguage: "en",gaTrack: true,gaId: "UA-27188110-1",multilanguagePage: true});}</script><script src="//translate.google.com/translate_a/element.js?cb=googleTranslateElementInit"></script><meta name="DC.type" content="Patent"><meta name="DC.title" content="Test device and method for colored particle immunoassay"><meta name="DC.contributor" content="David E. Charlton" scheme="inventor"><meta name="DC.contributor" content="Armkel, Llc" scheme="assignee"><meta name="DC.date" content="1995-6-6" scheme="dateSubmitted"><meta name="DC.description" content="Disclosed is a test cell and a method for detection of a preselected ligand in a liquid sample such as a body fluid. The test cell includes an elongate outer casing which houses an interior permeable material capable of transporting an aqueous solution and defining a sample inlet, a test volume, and a reservoir volume. The reservoir volume is disposed in a section of the test cell spaced apart from the inlet and is filled with sorbent material. The reservoir acts to receive liquid transported along a flow path defined by the permeable material and extending from the inlet and through the test volume. In the test volume is a test site which includes a first protein having a binding site specific to a first epitope of the ligand immobilized in fluid communication with the flow path. The test site can be observed through a window of the casing."><meta name="DC.date" content="2002-11-26" scheme="issued"><meta name="DC.relation" content="US:3620677" scheme="references"><meta name="DC.relation" content="US:3811840" scheme="references"><meta name="DC.relation" content="US:3888629" scheme="references"><meta name="DC.relation" content="US:4042335" scheme="references"><meta name="DC.relation" content="US:4045384" scheme="references"><meta name="DC.relation" content="US:4094647" scheme="references"><meta name="DC.relation" content="US:4168146" scheme="references"><meta name="DC.relation" content="US:4169138" scheme="references"><meta name="DC.relation" content="US:4205952" scheme="references"><meta name="DC.relation" content="US:4219335" scheme="references"><meta name="DC.relation" content="US:4235601" scheme="references"><meta name="DC.relation" content="US:4256834" scheme="references"><meta name="DC.relation" content="US:4258001" scheme="references"><meta name="DC.relation" content="US:4294818" scheme="references"><meta name="DC.relation" content="US:4297344" scheme="references"><meta name="DC.relation" content="US:4313734" scheme="references"><meta name="DC.relation" content="US:4348207" scheme="references"><meta name="DC.relation" content="US:4357142" scheme="references"><meta name="DC.relation" content="US:4361537" scheme="references"><meta name="DC.relation" content="US:4366241" scheme="references"><meta name="DC.relation" content="US:4373932" scheme="references"><meta name="DC.relation" content="US:4376110" scheme="references"><meta name="DC.relation" content="US:4411518" scheme="references"><meta name="DC.relation" content="US:4419453" scheme="references"><meta name="DC.relation" content="US:4434150" scheme="references"><meta name="DC.relation" content="US:4435504" scheme="references"><meta name="DC.relation" content="US:4446232" scheme="references"><meta name="DC.relation" content="US:4459358" scheme="references"><meta name="DC.relation" content="US:4477575" scheme="references"><meta name="DC.relation" content="US:4486530" scheme="references"><meta name="DC.relation" content="US:4487839" scheme="references"><meta name="DC.relation" content="US:4496654" scheme="references"><meta name="DC.relation" content="US:4503143" scheme="references"><meta name="DC.relation" content="US:4508829" scheme="references"><meta name="DC.relation" content="US:4515889" scheme="references"><meta name="DC.relation" content="US:4537861" scheme="references"><meta name="DC.relation" content="US:4552839" scheme="references"><meta name="DC.relation" content="US:4590169" scheme="references"><meta name="DC.relation" content="US:4594327" scheme="references"><meta name="DC.relation" content="US:4604364" scheme="references"><meta name="DC.relation" content="US:4623461" scheme="references"><meta name="DC.relation" content="US:4624929" scheme="references"><meta name="DC.relation" content="US:4632901" scheme="references"><meta name="DC.relation" content="US:4639242" scheme="references"><meta name="DC.relation" content="US:4639419" scheme="references"><meta name="DC.relation" content="US:4647544" scheme="references"><meta name="DC.relation" content="US:4654309" scheme="references"><meta name="DC.relation" content="US:4665034" scheme="references"><meta name="DC.relation" content="US:4666863" scheme="references"><meta name="DC.relation" content="US:4690907" scheme="references"><meta name="DC.relation" content="US:4703017" scheme="references"><meta name="DC.relation" content="US:4740468" scheme="references"><meta name="DC.relation" content="US:4756828" scheme="references"><meta name="DC.relation" content="US:4757004" scheme="references"><meta name="DC.relation" content="US:4761381" scheme="references"><meta name="DC.relation" content="US:4770853" scheme="references"><meta name="DC.relation" content="US:4772550" scheme="references"><meta name="DC.relation" content="US:4774192" scheme="references"><meta name="DC.relation" content="US:4778751" scheme="references"><meta name="DC.relation" content="US:4803170" scheme="references"><meta name="DC.relation" content="US:4806311" scheme="references"><meta name="DC.relation" content="US:4806312" scheme="references"><meta name="DC.relation" content="US:4853335" scheme="references"><meta name="DC.relation" content="US:4857453" scheme="references"><meta name="DC.relation" content="US:4859612" scheme="references"><meta name="DC.relation" content="US:4861711" scheme="references"><meta name="DC.relation" content="US:4868108" scheme="references"><meta name="DC.relation" content="US:4879215" scheme="references"><meta name="DC.relation" content="US:4883688" scheme="references"><meta name="DC.relation" content="US:4891313" scheme="references"><meta name="DC.relation" content="US:4916056" scheme="references"><meta name="DC.relation" content="US:4920046" scheme="references"><meta name="DC.relation" content="US:4945042" scheme="references"><meta name="DC.relation" content="US:4954452" scheme="references"><meta name="DC.relation" content="US:4956302" scheme="references"><meta name="DC.relation" content="US:4959307" scheme="references"><meta name="DC.relation" content="US:4960691" scheme="references"><meta name="DC.relation" content="US:4962023" scheme="references"><meta name="DC.relation" content="US:4963468" scheme="references"><meta name="DC.relation" content="US:4981785" scheme="references"><meta name="DC.relation" content="US:4981786" scheme="references"><meta name="DC.relation" content="US:4985204" scheme="references"><meta name="DC.relation" content="US:4999285" scheme="references"><meta name="DC.relation" content="US:5006474" scheme="references"><meta name="DC.relation" content="US:5008080" scheme="references"><meta name="DC.relation" content="US:5030558" scheme="references"><meta name="DC.relation" content="US:5039607" scheme="references"><meta name="DC.relation" content="US:5043428" scheme="references"><meta name="DC.relation" content="US:5073484" scheme="references"><meta name="DC.relation" content="US:5075078" scheme="references"><meta name="DC.relation" content="US:5085987" scheme="references"><meta name="DC.relation" content="US:5085988" scheme="references"><meta name="DC.relation" content="US:5120504" scheme="references"><meta name="DC.relation" content="US:5120643" scheme="references"><meta name="DC.relation" content="US:5141850" scheme="references"><meta name="DC.relation" content="US:5141875" scheme="references"><meta name="DC.relation" content="US:5149622" scheme="references"><meta name="DC.relation" content="US:5156952" scheme="references"><meta name="DC.relation" content="US:5160701" scheme="references"><meta name="DC.relation" content="US:RE30267" scheme="references"><meta name="citation_reference" content="&quot;Polar Bear Hits Town; OPUS Immunoassay System&quot;, Diagnostic News, issue 1, Mar. 1992, Behring. pp. 73-75."><meta name="citation_reference" content="&quot;Summary of Pregslide 00 see Test Specifications&quot;, XII World Congress on Fertility &amp; Sterility, Singapore, 1986."><meta name="citation_reference" content="Baker, T.S., &quot;Letter to Crawford G.L.: Clarification of Dual Analyte Protocols&quot;. 1983."><meta name="citation_reference" content="Bosch, A.M. G., &quot;Enzym-und Sol Particle Immunoassays für Hormone&quot;, Gynecology and Obstetrics, pp. 509-512; 1987. English summary 1 page."><meta name="citation_reference" content="Brdicka, R., &quot;Grundlagen Der Physikalischen Chemie&quot;, Ch. X. pp. 774-787; Veb Deutscher Verlag Der Wissenschaften, Berlin (1958). English summary 1 page."><meta name="citation_reference" content="Bredig-Leipzig, &quot;Einige Anwendungen Des Elektnschen Lichtbogens&quot;, Zietschrist Für Electrochemie, Heft. 22, pp. 514-515; (1898). English summary 1 page."><meta name="citation_reference" content="Chard, T., &quot;Pregnancy Tests: A Review&quot;, Human Reproduction, vol. 7, No. 5, pp. 701-710, 1952."><meta name="citation_reference" content="Chemical Abstracts 53: 18745 issued 1959, Werdmann et al., &quot;Paper chromatographic separation of copper (II), silver (I), and gold (III),&quot; Osterr. Chemiker Ztg. 60 : 138-139 (1959)."><meta name="citation_reference" content="Chemical Abstracts v 5 p. 3753 issued 1911, Fichter et al., &quot;The capillary analyses of colloidal, solutions,&quot; Verhandl Naturforsch. Ges. Basel 21 (1910) 1-24."><meta name="citation_reference" content="Chemical Abstracts v 5 p. 3753 issued 1911, Fichter, Z. Chem. Ind. Kolloide, 8 (1911):1-2."><meta name="citation_reference" content="Collins, H.W.P., &quot;Alternative Immunoassays&quot;, Ed. John Wiley &amp; Sons, 1985 pp. 34-57."><meta name="citation_reference" content="Collins, W.P.&#39; Statutory Declaration, In the matter of European Patent Application No. 88303744.2-2116 in the name of Unilever NV, 1992."><meta name="citation_reference" content="Collins, W.P., &quot;Statutory Declaration No. 2&quot;, In the Matter of European Patent Application No. 88303744.2/291,194, In the Name of Unilever NV and Oppositions Thereto, 1995."><meta name="citation_reference" content="Collins, W.P.; &quot;Expert Report&quot;; In the High Court of Justice, Chancery Division, Patent Court; Unilever PLC v. Chefaro Proprietaries Ltd., 1994."><meta name="citation_reference" content="Colloidal Metal Marking Reference Book (1984-85), vol. 2, No. 1, pp. 1-44."><meta name="citation_reference" content="E. Blasius and M. Fischer, Papierchromatographische und papierionophoretische Trennung der Elemente der Reduktiongruppe, 178 Z. Anal. Chem. (1960). pp. 28-33 No English translation."><meta name="citation_reference" content="E. Blasius and M. Fischer, Papierchromatographische und papierionophoretische Trennung der Platinelemente und des Goldes, 177 Z. Anal. Chem. (1960), pp. 412-420 No English translation."><meta name="citation_reference" content="F. Goppelstroder, Verhandl 3 Naturforsch. Ges. Basel 268 (1861)."><meta name="citation_reference" content="Fichter, et al., Die Kapillaranalyse Kolloidaler Lösungen, 21 Verhandl Naturforsch.Ges.Basel 2-24 (1910). No English translation."><meta name="citation_reference" content="Fichter, Ueber die kapillarelektrische Fällung positiver Kolloide Zeitschrift Für Chemie Und Industrie Der Kolliode 1-2 (1911). No English translation."><meta name="citation_reference" content="Frens, &quot;Controlled Nucleation for the Regulation of the Particle Size in Monodisperse Gold Suspensions,&quot; 241 Nature Physical Science 20-22 (1973)."><meta name="citation_reference" content="Giles, A.B., &quot;Witness Statement&quot;, In the High Court of Justice, Chancery Division, Patent, Court, Unilever PLC v. Chefaro Proprietaries Ltd.; CH 1993. U. No. 3034; 1994."><meta name="citation_reference" content="Glad, C. et al.; &quot;Immunocapillarymigration-A new Method for Immunochemical Quantitation&quot;, Analytical Biochemistry, 85, 180-187 (1978)."><meta name="citation_reference" content="Glad, C. et al.; “Immunocapillarymigration—A new Method for Immunochemical Quantitation”, Analytical Biochemistry, 85, 180-187 (1978)."><meta name="citation_reference" content="Greenquist et al., &quot;Homogenous Fluorescent Immunoassay with Dry Re-agents,&quot; Clinical Chemistry, vol. 27, No. 9, 1981 pp. 1614-1617."><meta name="citation_reference" content="Gribnau, et al., Particle-Labelled Immunoassays: A Review, 376 J. of Chromatography Biomedical Applications 175-189 (1986)."><meta name="citation_reference" content="H. Weil, Der Ursprung der Papierchromatographie, 40 Naturwissenschaften (1953), pp. 1-7 No English Translation."><meta name="citation_reference" content="H. Weil, The Evolution of Paper Chromatography, 132 Kolloid-Z (1953), pp. 149-162."><meta name="citation_reference" content="Heap, R.B., et al., &quot;Mechanisms of Transfer of Steroid Hormones and Growth Factors into Milk&quot;, Endocrinologia Experimentalis, vol. 20, pp 101-118; 1986."><meta name="citation_reference" content="Horisberger, &quot;Evaluation of Colloidal Gold as a Cytochromic Marker for Transmission and Scanning Electron Microscopy,&quot; 36 Biol. Cellulaire 253-58 (1979)."><meta name="citation_reference" content="Hsu, Y.-H. , &quot;Immunogold for Detection of Antigen on Nitrocellulose Paper&quot; Anal. Biochem., 142, 221-225, 1984."><meta name="citation_reference" content="J. Perrin, Mécanisme de L&#39;Electrisation de Contact et Solutions Colloidales, Tome III J. De Chimie Physique 50-160 (1905). No English translation."><meta name="citation_reference" content="J. Perrin, Mécanisme de L&#39;Electrisation de Contact et Solutions Colloidales, Tome III J. De Chimie Physique 601-51 (1904). No English translation."><meta name="citation_reference" content="Johannsson, A., et al., &quot;A Fast Highly Sensitive Colorimetric Enzyme Immunoassay System Demonstrating Benefits of Enzyme Amplifications in Clinical Chemistry&quot;, Clinica Chemica Acta, 148, 119-124, (1985)."><meta name="citation_reference" content="Johannsson, A., et al., &quot;Enzyme Amplification for Immunoassays Detection Limit of One Hundredth of an Attomole&quot;, J. Immunological Methods, 87 7-11 (1986)."><meta name="citation_reference" content="Kronick, M.N., &quot;Immunoassay Techniques with Fluorescent Phycobiliprotein Conjugates&quot;, Clinical Chemistry, 29/9, 1582-1586, 1983."><meta name="citation_reference" content="Lederer, M., &quot;Chromatographic Properties of Two Gold Compounds Used in the Therapy of Polyarthritis&quot;, 153 Journal of Chromatography, 302-304 (1978)."><meta name="citation_reference" content="Leuvering, et al, &quot;Sol Particle Immunoassay (SPIA),&quot; 1 (1) J. Immunoassay 77-91 (1980)."><meta name="citation_reference" content="Leuvering, et al., Optimization of a Sandwich Sol Particle Immunoasay for Human Chorionic Gonadotrophin, 62 J. Of Immunological Methods 175-184 (1983)."><meta name="citation_reference" content="Lou, et al., One-Step Competitive Immunochromatographic Assay for Semiquantitative Determination of Lipoprotein(a) in Plasma, 39(4) Clin. Chem 619-624 (1993)."><meta name="citation_reference" content="Maguire T.A., &quot;Pregnancy and Ovulation Testing&quot;; The Pharmaceutical Journal , 531-533, (1989), May 6."><meta name="citation_reference" content="May, K., &quot;Witness Statement&quot;, In the High Court of Justice, Chancery Division, Patent Court, Unilever PLC v. Chefaro Proprietaries Ltd.; 1993."><meta name="citation_reference" content="Moeremans, M., et al., &quot;Sensitive Visualization of Antigen-Assays with Immunogold and Immunogold/Silver Staining&quot;, J. Immunological Methods, 74, pp. 353-360, 1984."><meta name="citation_reference" content="Moss, D.W., et al., &quot;An Enzyme-Amplified Monoclonal Immunoenzymometric Assay for Prostatic Acid Phosphatase&quot;, Clinica Chimica Acta, 152, 85-94 (1985)."><meta name="citation_reference" content="Puissieux, F et al., &quot;Les Liposomes; Applications Therapeutiques&quot; Technique et Documentation (Lavoisier) 1985, Ch. 2, p. 48 (French, with translation)."><meta name="citation_reference" content="Runge, Die Runft der Farbenbereitung, Farbenchemie (1980). 1-288 No English translation."><meta name="citation_reference" content="Sahlbom, V.N., &quot;Kapilaranalyse Kolloider Lösungen&quot;, 2 Kolloidchemische Beihefte, Band II, Heft 3-4, pp. 79-140, Verlag Von Theodor Steinkopff, Dresden-A (1910-11). No English translation."><meta name="citation_reference" content="Stanley, C.J., &quot;Affidavit&quot;, In the Matter of European Patent No. 291,194 to Unilever, NV and In the Matter of Opposition Thereto, 1994."><meta name="citation_reference" content="Stanley, C.J., &quot;Witness Statement&quot;, In the High Court of Justice, Chancery Division, Patent Court Unilever PLC v. Chefaro Proprietaries Ltd., 1994."><meta name="citation_reference" content="Stanley, C.J., et al., &quot;Amperometric Enzyme-Amplified Immunoassays&quot;, J. Immunological Methods, 112, 153-161, 1988."><meta name="citation_reference" content="Stanley, C.J., et al., &quot;Enzyme Amplification Can Enhance Both the Speed and the Sensitivity of Immunoassays&quot;, J. Immunological Methods, 83, 89-95 (1985)."><meta name="citation_reference" content="Stanley, C.J., et al., &quot;Enzyme Amplification: A New Technique for Enhancing the Speed and Sensitivity of Enzyme Immunoassays&quot;, I.C.P.R., 44-51; Jul./Aug. 1985."><meta name="citation_reference" content="Stanley, C.J., et al., &quot;Enzyme-Amplified Immunoassays&quot;, J. Pharmaceutical and Biomedical Analysis, vol. 5, No. 8, pp. 811-820, 1987."><meta name="citation_reference" content="Stanley, C.J., et al., &quot;Use of a New and Rapid Milk Progesterone Assay to Monitor Reproductive Activity in the Cow&quot;, The Veterinarian Record, Jun. 14, 1986, pp. 664-667."><meta name="citation_reference" content="Surek, B. &quot;Visualization of Antigenic Proteins Blotted onto Nitrocellulose Using The Immuno-Gold Staining (IGS) Method&quot; Biochemical and Biophysical Research Communications, 121 (1), 284-289, 1984."><meta name="citation_reference" content="Syva, Syntex Company, Product Brochure &quot;Acculevel; Acculevel TDM Assays&quot;, pp. 1-6, Sep. 1987."><meta name="citation_reference" content="Tijssen, Laboratory Techniques in Biochemistry and Molecular Biology, vol. 15, &quot;Practice and Theory of Enzyme Immunoassays,&quot; Chapter 13-The Immobilization of Immunoreactants on Solid Phases, 297-328."><meta name="citation_reference" content="Tijssen, Laboratory Techniques in Biochemistry and Molecular Biology, vol. 15, “Practice and Theory of Enzyme Immunoassays,” Chapter 13—The Immobilization of Immunoreactants on Solid Phases, 297-328."><meta name="citation_reference" content="Unanue, E.R., Benacerraf, B.; &quot;Immunfluoreszenz&quot;; Immunologie, pp. 63-65; Walter de Gruyter, Berlin-New York 1987. English Translation."><meta name="citation_reference" content="Van Hell, H., et al., &quot;Particle Immunoassays&quot;; Alternative Immunoassays, Ch. 4, pp. 40-59; 1985."><meta name="citation_reference" content="Verheijden, P., &quot;Witness Statement&quot;, In the High Court of Justice, Chancery Division, Patent Court, Unilever PLC v. Chefaro Proprietaries Ltd., 1994."><meta name="citation_reference" content="Welch, P.G., &quot;Witness Statement&quot;, In the High Court of Justice, Chancery Division, Patent Court; Unilever PLC v. Chefaro Proprietaries Ltd.; 1994."><meta name="citation_reference" content="Wiberg, E., &quot;Lehrbuch Der Anorganischen Chemie&quot;, pp. 333-338, Walter De Gruyte &amp; Co., Berlin, 1960. 1 page English Summary."><meta name="citation_reference" content="Worsfold, A.I., et al., &quot;The Evaluation of a New Rapid Milk Progesterone Test as an Aid to Improving Dairy Herd Fertility&quot;, British Veterinary Journal, 143, 83-87, 1987."><meta name="citation_reference" content="Wright, J.F.; &quot;A Simple Immunodiagnostic Test System for Alternate Site Market&quot;; World Biotech Report, pp. 263-271; 1988."><meta name="citation_reference" content="Zsigmondy, R.; &quot;Ueber Wassrige Lösungen Metallischer Goldes&quot;, Annalen Der Chemie, 301, pp. 29-54; 1898. English Translation by Morgan C. Larkin."><meta name="citation_reference" content="Zuk, R.F., et al., Enzyme Immunochromatography-A Quantitative Immunoassay Requiring No Instrumentation, Clinical Chemistry, vol. 31, No. 7, pp. 1145-1150 (1985)."><meta name="citation_reference" content="Zuk, R.F., et al., Enzyme Immunochromatography—A Quantitative Immunoassay Requiring No Instrumentation, Clinical Chemistry, vol. 31, No. 7, pp. 1145-1150 (1985)."><meta name="citation_patent_number" content="US:6485982"><meta name="citation_patent_application_number" content="US:08/465,675"><link rel="canonical" href="http://www.google.com/patents/US6485982"/><meta property="og:url" content="http://www.google.com/patents/US6485982"/><meta name="title" content="Patent US6485982 - Test device and method for colored particle immunoassay"/><meta name="description" content="Disclosed is a test cell and a method for detection of a preselected ligand in a liquid sample such as a body fluid. The test cell includes an elongate outer casing which houses an interior permeable material capable of transporting an aqueous solution and defining a sample inlet, a test volume, and a reservoir volume. The reservoir volume is disposed in a section of the test cell spaced apart from the inlet and is filled with sorbent material. The reservoir acts to receive liquid transported along a flow path defined by the permeable material and extending from the inlet and through the test volume. In the test volume is a test site which includes a first protein having a binding site specific to a first epitope of the ligand immobilized in fluid communication with the flow path. The test site can be observed through a window of the casing."/><meta property="og:title" content="Patent US6485982 - Test device and method for colored particle immunoassay"/><meta property="og:type" content="book"/><meta property="og:site_name" content="Google Books"/><meta property="og:image" content="http://www.google.com/patents?id=&amp;printsec=frontcover&amp;img=1&amp;zoom=1"/><link rel="image_src" href="http://www.google.com/patents?id=&amp;printsec=frontcover&amp;img=1&amp;zoom=1"/><script>(function(){try{var aa=function(a,b,c,d){d=d||{};d._sn=["cfg",b,c].join(".");window.gbar.logger.ml(a,d)};var g=window.gbar=window.gbar||{},l=window.gbar.i=window.gbar.i||{},m={},n;function _tvn(a,b){var c=parseInt(a,10);return isNaN(c)?b:c}function _tvf(a,b){var c=parseFloat(a);return isNaN(c)?b:c}function _tvv(a){return!!a}function p(a,b,c){(c||g)[a]=b}g.bv={n:_tvn("2",0),r:"",f:".67.",e:"0",m:_tvn("0",1)};
function q(a,b,c){var d="on"+b;if(a.addEventListener)a.addEventListener(b,c,!1);else if(a.attachEvent)a.attachEvent(d,c);else{var f=a[d];a[d]=function(){var a=f.apply(this,arguments),b=c.apply(this,arguments);return void 0==a?b:void 0==b?a:b&&a}}}var s=function(a){return function(){return g.bv.m==a}},ba=s(1),ca=s(2);p("sb",ba);p("kn",ca);l.a=_tvv;l.b=_tvf;l.c=_tvn;l.i=aa;var da=window.gbar.i.i;var t,u,v,w;function ea(a){v=a}function fa(a){var b;if(b=v&&window.encodeURIComponent)b=a.href,b=!b.match(/^http[s]?:\/\/accounts\.google\.[^/]*\/ClearSID/i)&&!b.match(/^http[s]?:\/\/[^/]*\/accounts\/ClearSID/i);if(b=b&&encodeURIComponent(v()))a.href=a.href.replace(/([?&]continue=)[^&]*/,"$1"+b)}function ga(a){window.gApplication&&(a.href=window.gApplication.getTabUrl(a.href))}
function ha(a){var b=document.forms[0].q,c=window.encodeURIComponent&&b&&b.value,b=b&&b.placeholder;c&&c!=b&&(a.href=a.href.replace(/([?&])q=[^&]*|$/,function(a,b){return(b||"&")+"q="+encodeURIComponent(c)}))}n=l.a("")?ga:ha;
function x(a,b,c,d,f,e){var h=document.getElementById(a);if(h){var k=h.style;k.left=d?"auto":b+"px";k.right=d?b+"px":"auto";k.top=c+"px";k.visibility=u?"hidden":"visible";f&&e?(k.width=f+"px",k.height=e+"px"):(x(t,b,c,d,h.offsetWidth,h.offsetHeight),u=u?"":a)}}
var y=[],ia=function(a,b){y.push(b)},ja=function(a){a=a||window.event;var b=a.target||a.srcElement;a.cancelBubble=!0;null==t&&(a=document.createElement(Array.every||window.createPopup?"iframe":"div"),a.frameBorder="0",t=a.id="gbs",a.src="javascript:''",b.parentNode.appendChild(a),q(document,"click",z));var c=b,b=0;"gb3"!=c.className&&(c=c.parentNode);a=c.getAttribute("aria-owns")||"gbi";var d=c.offsetWidth,f=20<c.offsetTop?46:24;document.getElementById("tphdr")&&(f-=3);var e=!1;do b+=c.offsetLeft||
0;while(c=c.offsetParent);var c=(document.documentElement.clientWidth||document.body.clientWidth)-b-d,h,d=document.body,k=document.defaultView;k&&k.getComputedStyle?(d=k.getComputedStyle(d,""))&&(h=d.direction):h=d.currentStyle?d.currentStyle.direction:d.style.direction;h="rtl"==h;if("gbi"==a){for(d=0;k=y[d++];)k();A(null,window.navExtra);h&&(b=c,e=!0)}else h||(b=c,e=!0);u!=a&&z();x(a,b,f,e)},z=function(){u&&x(u,0,0)},A=function(a,b){var c,d=document.getElementById("gbi"),f=a;f||(f=d.firstChild);
for(;b&&(c=b.pop());){var e=d,h=c,k=f;w||(w="gb2");e.insertBefore(h,k).className=w}},ka=function(a,b,c){if((b=document.getElementById(b))&&a){a.className="gb4";var d=document.createElement("span");d.appendChild(a);d.appendChild(document.createTextNode(" | "));d.id=c;b.appendChild(d)}},la=function(){return document.getElementById("gb_70")},ma=function(){return!!u};p("qs",n);p("setContinueCb",ea);p("pc",fa);p("tg",ja);p("close",z);p("addLink",ka);p("almm",A);p("si",la);p("adh",ia);p("op",ma);var B=function(){},C=function(){},F=function(a){var b=new Image,c=D;b.onerror=b.onload=b.onabort=function(){try{delete E[c]}catch(a){}};E[c]=b;b.src=a;D=c+1},E=[],D=0;p("logger",{il:C,ml:B,log:F});var G=window.gbar.logger;var H={},na={},I=[],oa=l.b("0.1",.1),pa=l.a("1",!0),qa=function(a,b){I.push([a,b])},ra=function(a,b){H[a]=b},sa=function(a){return a in H},J={},K=function(a,b){J[a]||(J[a]=[]);J[a].push(b)},ta=function(a){K("m",a)},L=function(a,b){var c=document.createElement("script");c.src=a;c.async=pa;Math.random()<oa&&(c.onerror=function(){c.onerror=null;B(Error("Bundle load failed: name="+(b||"UNK")+" url="+a))});(document.getElementById("xjsc")||document.getElementsByTagName("body")[0]||
document.getElementsByTagName("head")[0]).appendChild(c)},N=function(a){for(var b=0,c;(c=I[b])&&c[0]!=a;++b);!c||c[1].l||c[1].s||(c[1].s=!0,M(2,a),c[1].url&&L(c[1].url,a),c[1].libs&&m.d&&m.d(c[1].libs))},O=function(a){K("gc",a)},P=null,ua=function(a){P=a},M=function(a,b,c){if(P){a={t:a,b:b};if(c)for(var d in c)a[d]=c[d];try{P(a)}catch(f){}}};p("mdc",H);p("mdi",na);p("bnc",I);p("qGC",O);p("qm",ta);p("qd",J);p("lb",N);p("mcf",ra);p("bcf",qa);p("aq",K);p("mdd","");p("has",sa);
p("trh",ua);p("tev",M);var Q=l.b("0.1",.001),R=0;
function _mlToken(a,b){try{if(1>R){R++;var c,d=a,f=b||{},e=encodeURIComponent,h=["//www.google.com/gen_204?atyp=i&zx=",(new Date).getTime(),"&jexpid=",e("17483"),"&srcpg=",e("prop=22"),"&jsr=",Math.round(1/Q),"&ogev=",e("0avtU6O_FrGxsAThxICIBw"),"&ogf=",g.bv.f,"&ogrp=",e("1"),"&ogv=",e("1407723702.0"),"&oggv="+e("es_plusone_gc_20140723.0_p0"),"&ogd=",e("com"),"&ogc=",e("PAN"),"&ogl=",e("en")];f._sn&&(f._sn="og."+
f._sn);for(var k in f)h.push("&"),h.push(e(k)),h.push("="),h.push(e(f[k]));h.push("&emsg=");h.push(e(d.name+":"+d.message));var r=h.join("");S(r)&&(r=r.substr(0,2E3));c=r;var Aa=window.gbar.logger._aem(a,c);F(Aa)}}catch(Na){}}var S=function(a){return 2E3<=a.length},va=function(a,b){return b};function T(a){B=a;p("_itl",S,G);p("_aem",va,G);p("ml",B,G);a={};H.er=a}l.a("")?T(function(a){throw a;}):l.a("1")&&Math.random()<Q&&T(_mlToken);I.push(["m",{url:"//ssl.gstatic.com/gb/js/scm_7385cc5883250b43a39405734c1bea59.js"}]);g.mcf("c",{});g.sg={c:""};if(l.a("1")){var wa=l.a("");I.push(["gc",{auto:wa,url:"//ssl.gstatic.com/gb/js/abc/gci_91f30755d6a6b787dcc2a4062e6e9824.js",libs:"googleapis.client:plusone:gapi.iframes"}]);var xa={version:"gci_91f30755d6a6b787dcc2a4062e6e9824.js",index:"",lang:"en"};H.gc=xa;var U=function(a){window.googleapis&&window.iframes?a&&a():(a&&O(a),N("gc"))};p("lGC",U);l.a("1")&&p("lPWF",U)};window.__PVT="";if(l.a("1")&&l.a("1")){var V=function(a){U(function(){K("pw",a);N("pw")})};p("lPW",V);I.push(["pw",{url:"//ssl.gstatic.com/gb/js/abc/pwm_45f73e4df07a0e388b0fa1f3d30e7280.js"}]);var W=[],ya=function(a){W[0]=a},za=function(a,b){var c=b||{};c._sn="pw";B(a,c)},Ba={signed:W,elog:za,base:"https://plusone.google.com/u/0",loadTime:(new Date).getTime()};H.pw=Ba;var X=function(a,b){for(var c=b.split("."),d=function(){var b=arguments;a(function(){for(var a=g,d=0,e=c.length-1;d<e;++d)a=a[c[d]];a[c[d]].apply(a,b)})},f=g,e=0,h=c.length-1;e<h;++e)f=
f[c[e]]=f[c[e]]||{};return f[c[e]]=d};X(V,"pw.clk");X(V,"pw.hvr");p("su",ya,g.pw)};function Ca(){function a(){for(var b;(b=e[h++])&&"m"!=b[0]&&!b[1].auto;);b&&(M(2,b[0]),b[1].url&&L(b[1].url,b[0]),b[1].libs&&m.d&&m.d(b[1].libs));h<e.length&&setTimeout(a,0)}function b(){0<f--?setTimeout(b,0):a()}var c=l.a("1"),d=l.a(""),f=3,e=I,h=0,k=window.gbarOnReady;if(k)try{k()}catch(r){da(r,"ml","or")}d?p("ldb",a):c?q(window,"load",b):b()}p("rdl",Ca);var Da={D:1,H:2,da:3,p:4,W:5,M:6,F:7,g:8,ha:9,U:10,L:11,T:12,S:13,N:14,Q:15,P:16,fa:17,w:18,O:19,ga:20,ea:21,u:22,G:23,ja:24,ka:25,ia:26,A:27,j:28,o:29,k:30,ca:31,Z:32,$:33,J:34,K:35,ba:36,aa:37,Y:38,B:39,R:40,v:41,X:42,V:43,h:48,C:49,I:500},Y=[1,2,3,4,5,6,9,10,11,13,14,28,29,30,34,35,37,38,39,40,41,42,43,48,49,500];var Z=l.b("0.001",1E-4),Ea=l.b("1",1),Fa=!1,Ga=!1;if(l.a("1")){var Ha=Math.random();Ha<=Z&&(Fa=!0);Ha<=Ea&&(Ga=!0)}var Ia=Da,$=null;function Ja(){var a=0,b=function(b,d){l.a(d)&&(a|=b)};b(1,"");b(2,"");b(4,"");b(8,"");return a}
function Ka(a,b){var c=Z,d=Fa,f;f=a;if(!$){$={};for(var e=0;e<Y.length;e++){var h=Y[e];$[h]=!0}}if(f=!!$[f])c=Ea,d=Ga;if(d){d=encodeURIComponent;g.rp?(f=g.rp(),f="-1"!=f?f:"1"):f="1";c=["//www.google.com/gen_204?atyp=i&zx=",(new Date).getTime(),"&oge=",a,"&ogex=",d("17483"),"&ogev=",d("0avtU6O_FrGxsAThxICIBw"),"&ogf=",g.bv.f,"&ogp=",d("22"),"&ogrp=",d(f),"&ogsr=",Math.round(1/c),"&ogv=",d("1407723702.0"),"&oggv="+
d("es_plusone_gc_20140723.0_p0"),"&ogd=",d("com"),"&ogl=",d("en"),"&ogc=",d("PAN"),"&ogus=",Ja()];if(b){"ogw"in b&&(c.push("&ogw="+b.ogw),delete b.ogw);var k;f=b;e=[];for(k in f)0!=e.length&&e.push(","),e.push(La(k)),e.push("."),e.push(La(f[k]));k=e.join("");""!=k&&(c.push("&ogad="),c.push(d(k)))}F(c.join(""))}}function La(a){"number"==typeof a&&(a+="");return"string"==typeof a?a.replace(".","%2E").replace(",","%2C"):a}C=Ka;p("il",C,G);var Ma={};H.il=Ma;setTimeout(function(){C(Ia.g)},0);}catch(e){window.gbar&&gbar.logger&&gbar.logger.ml(e,{"_sn":"cfg.init"});}})();
(function(){try{var b=window.gbar.i.i;var c=window.gbar;var f=function(d){try{var a=document.getElementById("gbom");a&&d.appendChild(a.cloneNode(!0))}catch(e){b(e,"omas","aomc")}};c.aomc=f;}catch(e){window.gbar&&gbar.logger&&gbar.logger.ml(e,{"_sn":"cfg.init"});}})();
(function(){try{var a=window.gbar;a.mcf("pm",{p:""});}catch(e){window.gbar&&gbar.logger&&gbar.logger.ml(e,{"_sn":"cfg.init"});}})();
(function(){try{window.gbar.rdl();}catch(e){window.gbar&&gbar.logger&&gbar.logger.ml(e,{"_sn":"cfg.init"});}})();
if (window['_OC_timingAction']) {window['_OC_timingAction']('patents_refpage');}</script><style>#gbar,#guser{font-size:13px;padding-top:1px !important;}#gbar{float:left;height:22px}#guser{padding-bottom:7px !important;text-align:right}.gbh,.gbd{border-top:1px solid #c9d7f1;font-size:1px}.gbh{height:0;position:absolute;top:24px;width:100%}#gbs,.gbm{background:#fff;left:0;position:absolute;text-align:left;visibility:hidden;z-index:1000}.gbm{border:1px solid;border-color:#c9d7f1 #36c #36c #a2bae7;z-index:1001}.gb1{margin-right:.5em}.gb1,.gb3{zoom:1}.gb2{display:block;padding:.2em .5em}.gb2,.gb3{text-decoration:none !important;border-bottom:none}a.gb1,a.gb4{text-decoration:underline !important}a.gb1,a.gb2,a.gb3,a.gb4{color:#00c !important}.gbi .gb3,.gbi .gb2,.gbi .gb4{color:#dd8e27 !important}.gbf .gb3,.gbf .gb2,.gbf .gb4{color:#900 !important}a.gb2:hover{background:#36c;color:#fff !important}#gbar .gbz0l{color:#000 !important;cursor:default;font-weight:bold;text-decoration:none !important}
#gbar { padding:.3em .6em !important;}</style></head><body  topmargin="3" marginheight="3"><div id=gbar><nobr><a onclick=gbar.qs(this);gbar.logger.il(1,{t:1}); class=gb1 id=gb_1 href="https://www.google.com/search?sa=N&tab=tw">Search</a> <a onclick=gbar.qs(this);gbar.logger.il(1,{t:2}); class=gb1 id=gb_2 href="http://www.google.com/search?hl=en&tbm=isch&source=og&sa=N&tab=ti">Images</a> <a onclick=gbar.qs(this);gbar.logger.il(1,{t:8}); class=gb1 id=gb_8 href="http://maps.google.com/maps?hl=en&sa=N&tab=tl">Maps</a> <a onclick=gbar.qs(this);gbar.logger.il(1,{t:78}); class=gb1 id=gb_78 href="https://play.google.com/?hl=en&sa=N&tab=t8">Play</a> <a onclick=gbar.qs(this);gbar.logger.il(1,{t:36}); class=gb1 id=gb_36 href="http://www.youtube.com/results?sa=N&tab=t1">YouTube</a> <a onclick=gbar.logger.il(1,{t:5}); class=gb1 id=gb_5 href="http://news.google.com/nwshp?hl=en&tab=tn">News</a> <a onclick=gbar.logger.il(1,{t:23}); class=gb1 id=gb_23 href="https://mail.google.com/mail/?tab=tm">Gmail</a> <a onclick=gbar.logger.il(1,{t:25}); class=gb1 id=gb_25 href="https://drive.google.com/?tab=to">Drive</a> <a class=gb3 href="http://www.google.com/intl/en/options/" onclick="this.blur();gbar.tg(event);return !1" aria-haspopup=true><u>More</u> <small>&#9660;</small></a><div class=gbm id=gbi><a onclick=gbar.logger.il(1,{t:24}); class=gb2 id=gb_24 href="https://www.google.com/calendar?tab=tc">Calendar</a><a onclick=gbar.qs(this);gbar.logger.il(1,{t:51}); class=gb2 id=gb_51 href="http://translate.google.com/?hl=en&sa=N&tab=tT">Translate</a><a onclick=gbar.logger.il(1,{t:17}); class=gb2 id=gb_17 href="http://www.google.com/mobile/?hl=en&tab=tD">Mobile</a><a onclick=gbar.qs(this);gbar.logger.il(1,{t:10}); class=gb2 id=gb_10 href="http://www.google.com/search?hl=en&tbo=u&tbm=bks&source=og&sa=N&tab=tp">Books</a><a onclick=gbar.logger.il(1,{t:212}); class=gb2 id=gb_212 href="https://wallet.google.com/manage/?tab=ta">Wallet</a><a onclick=gbar.qs(this);gbar.logger.il(1,{t:6}); class=gb2 id=gb_6 href="http://www.google.com/search?hl=en&tbo=u&tbm=shop&source=og&sa=N&tab=tf">Shopping</a><a onclick=gbar.logger.il(1,{t:30}); class=gb2 id=gb_30 href="http://www.blogger.com/?tab=tj">Blogger</a><a onclick=gbar.qs(this);gbar.logger.il(1,{t:27}); class=gb2 id=gb_27 href="http://www.google.com/finance?sa=N&tab=te">Finance</a><a onclick=gbar.qs(this);gbar.logger.il(1,{t:31}); class=gb2 id=gb_31 href="https://plus.google.com/photos?sa=N&tab=tq">Photos</a><a onclick=gbar.qs(this);gbar.logger.il(1,{t:12}); class=gb2 id=gb_12 href="http://www.google.com/search?hl=en&tbo=u&tbm=vid&source=og&sa=N&tab=tv">Videos</a><div class=gb2><div class=gbd></div></div><a onclick=gbar.logger.il(1,{t:66}); href="http://www.google.com/intl/en/options/" class=gb2>Even more &raquo;</a></div></nobr></div><div id=guser width=100%><nobr><span id=gbn class=gbi></span><span id=gbf class=gbf></span><span id=gbe></span><a target=_top id=gb_70 href="https://www.google.com/accounts/Login?service=&continue=http://www.google.com/patents%3Fhl%3Den&hl=en" class=gb4>Sign in</a><div style="display: none"><div class=gbm id=gbd5 aria-owner=gbg5><div class=gbmc><ol id=gbom class=gbmcc></ol></div></div></div></nobr></div><div class=gbh style=left:0></div><div class=gbh style=right:0></div><div role="alert" style="position: absolute; left: 0; right: 0;"><a href="http://www.google.com/patents/us6485982?hl=en&amp;output=html_text" title="Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader."><img border="0" src="http://www.google.com/images/cleardot.gif"alt="Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader."></a></div><div id="guser"><nobr></nobr></div><div style="clear:both;"></div><div id="gb-top-search-box" class="gb-top-search-box-small gb-reset"><table><tr><td class="logo"><a href="http://www.google.com/patents" class="logo-link"><img class="logo-img" src="/intl/en/images/logos/google_logo_41.png" alt="Go to Google Books Home" height="41"/></a></td><td><form action="http://www.google.com/search" name="f" id="vheadf" method="get"><span id="hf"></span><input type="hidden" name="tbm" value="pts"/><input type="hidden" name="tbo" value="1"/><input type="hidden" name="hl" value="en"/><table><tr><td><div class="inputs"><table><tr><td><div class="text-input"><input type="text" name="q" id="vheadq" class="text" maxlength="2048" size="31" value="" title="Search Patents" accesskey="s" autocomplete="off"/><script>window._OC_autoDir &&window._OC_autoDir('vheadq', 'tia-vheadq');</script></div></td><td><div class="submit-input"><input name="btnG" class="submit" type="submit" value=""/></div></td></tr></table></div></td><td class="col-ext-links"><div class="ext-links"><a href="http://www.google.com/advanced_patent_search">&lt;nobr&gt;Advanced Patent Search&lt;/nobr&gt;</a></div></td></tr></table></form></td></tr></table></div><div class="kd-appbar"><h2 class="kd-appname"><a href="/patents">Patents</a></h2><div class="kd-buttonbar left" id="left-toolbar-buttons"><a id="appbar-write-review-link" href=""></a><a id="appbar-view-print-sample-link" href=""></a><a id="appbar-view-ebook-sample-link" href=""></a><a id="appbar-patents-prior-art-finder-link" href="https://www.google.com/patents/related/US6485982"></a><a id="appbar-patents-discuss-this-link" href="http://www.google.com/url?id=mHNdBAABERAJ&amp;q=http://patents.stackexchange.com/redirect/google-patents%3Fpatent%3DUS6485982&amp;usg=AFQjCNGw0PMPD2_6SEKZgYX1nRu-_Tb_xQ" data-is-grant="true"></a><a id="appbar-read-patent-link" href="//docs.google.com/viewer?url=patentimages.storage.googleapis.com/pdfs/US6485982.pdf"></a><a id="appbar-download-pdf-link" href="//patentimages.storage.googleapis.com/pdfs/US6485982.pdf"></a></div><div class="kd-buttonbar right" id="right-toolbar-buttons"></div></div><div id="books-microdata" itemscope=""itemtype="http://schema.org/Book"itemid="http://www.google.com/patents/US6485982" style="display:none"><span itemprop="description">Disclosed is a test cell and a method for detection of a preselected ligand in a liquid sample such as a body fluid. The test cell includes an elongate outer casing which houses an interior permeable material capable of transporting an aqueous solution and defining a sample inlet, a test volume, and...</span><span itemprop="url">http://www.google.com/patents/US6485982?utm_source=gb-gplus-share</span><span class="main-title" itemprop="name">Patent US6485982 - Test device and method for colored particle immunoassay</span><img itemprop="image" src="http://www.google.com/patents?id=&amp;printsec=frontcover&amp;img=1&amp;zoom=1"alt="Patent US6485982 - Test device and method for colored particle immunoassay" title="Patent US6485982 - Test device and method for colored particle immunoassay"></div><div style="display: none"><ol id="ofe-gear-menu-contents" class="gbmcc"><li class="gbe gbmtc"><a class="gbmt goog-menuitem-content" id="" href="http://www.google.com/advanced_patent_search">Advanced Patent Search</a></li></ol></div><table id="viewport_table" cellpadding="0" style="clear:both" cellspacing="0"><tr><td id="viewport_td"><div class=vertical_module_list_row><div id=intl_patents class=about_content><div id=intl_patents_v><table class="patent-bibdata"><tr><td class="patent-bibdata-heading">Publication number</td><td class="single-patent-bibdata">US6485982 B1</td></tr><tr><td class="patent-bibdata-heading">Publication type</td><td class="single-patent-bibdata">Grant</td></tr><tr><td class="patent-bibdata-heading">Application number</td><td class="single-patent-bibdata">US 08/465,675</td></tr><tr><td class="patent-bibdata-heading">Publication date</td><td class="single-patent-bibdata">Nov 26, 2002</td></tr><tr><td class="patent-bibdata-heading">Filing date</td><td class="single-patent-bibdata">Jun 6, 1995</td></tr><tr><td class="patent-bibdata-heading">Priority date<span class="patent-tooltip-anchor patent-question-icon"data-tooltip-text="The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed."></span></td><td class="single-patent-bibdata">Jun 27, 1988</td></tr><tr><td class="patent-bibdata-heading">Fee status<span class="patent-tooltip-anchor patent-question-icon"data-tooltip-text="The fee status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status or dates listed."></span></td><td class="single-patent-bibdata">Paid</td></tr><tr class="patent-bibdata-list-row "><td class="patent-bibdata-heading">Also published as</td><td><span class="patent-bibdata-value-list"><span class="patent-bibdata-value"><a href="/patents/CA1340920C">CA1340920C</a>, </span><span class="patent-bibdata-value"><a href="/patents/DE68922148D1">DE68922148D1</a>, </span><span class="patent-bibdata-value"><a href="/patents/DE68922148T2">DE68922148T2</a>, </span><span class="patent-bibdata-value"><a href="/patents/EP0349215A1">EP0349215A1</a>, </span><span class="patent-bibdata-value"><a href="/patents/EP0349215B1">EP0349215B1</a>, </span><span class="patent-bibdata-value"><a href="/patents/US5714389">US5714389</a>, </span><span class="patent-bibdata-value"><a href="/patents/US5989921">US5989921</a>, </span><span class="patent-bibdata-value"><a href="/patents/US20060040405">US20060040405</a></span></span></td></tr><tr class="patent-bibdata-list-row alternate-patent-number"><td class="patent-bibdata-heading">Publication number</td><td><span class="patent-bibdata-value-list"><span class="patent-bibdata-value">08465675, </span><span class="patent-bibdata-value">465675, </span><span class="patent-bibdata-value">US 6485982 B1, </span><span class="patent-bibdata-value">US 6485982B1, </span><span class="patent-bibdata-value">US-B1-6485982, </span><span class="patent-bibdata-value">US6485982 B1, </span><span class="patent-bibdata-value">US6485982B1</span></span></td></tr><tr class="patent-bibdata-list-row "><td class="patent-bibdata-heading">Inventors</td><td><span class="patent-bibdata-value-list"><span class="patent-bibdata-value"><a href="http://www.google.com/search?tbo=p&tbm=pts&hl=en&q=ininventor:%22David+E.+Charlton%22">David E. Charlton</a></span></span></td></tr><tr class="patent-bibdata-list-row "><td class="patent-bibdata-heading">Original Assignee</td><td><span class="patent-bibdata-value-list"><span class="patent-bibdata-value"><a href="http://www.google.com/search?tbo=p&tbm=pts&hl=en&q=inassignee:%22Armkel,+Llc%22">Armkel, Llc</a></span></span></td></tr><tr class="patent-bibdata-list-row "><td class="patent-bibdata-heading">Export Citation</td><td><span class="patent-bibdata-value-list"><span class="patent-bibdata-value"><a href="/patents/US6485982.bibtex">BiBTeX</a>, </span><span class="patent-bibdata-value"><a href="/patents/US6485982.enw">EndNote</a>, </span><span class="patent-bibdata-value"><a href="/patents/US6485982.ris">RefMan</a></span></span></td></tr><tr class="patent-internal-links"><td colspan=2><span class="patent-bibdata-value"><a href="#backward-citations">Patent Citations</a> (100),</span> <span class="patent-bibdata-value"><a href="#npl-citations">Non-Patent Citations</a> (68),</span> <span class="patent-bibdata-value"><a href="#forward-citations">Referenced by</a> (86),</span> <span class="patent-bibdata-value"><a href="#classifications">Classifications</a> (44),</span> <span class="patent-bibdata-value"><a href="#legal-events">Legal Events</a> (8)</span> </td></tr><tr><td colspan=2 class="patent-bibdata-external-link-spacer-top"></td></tr><tr class="patent-bibdata-external-link-spacer-bottom"></tr><tr><td colspan=2><span class="patent-bibdata-heading">External Links:&nbsp;</span><span><span class="patent-bibdata-value"><a href="http://www.google.com/url?id=mHNdBAABERAJ&q=http://patft.uspto.gov/netacgi/nph-Parser%3FSect2%3DPTO1%26Sect2%3DHITOFF%26p%3D1%26u%3D/netahtml/PTO/search-bool.html%26r%3D1%26f%3DG%26l%3D50%26d%3DPALL%26RefSrch%3Dyes%26Query%3DPN/6485982&usg=AFQjCNFMnE02jDY1j8OaA5PJ5lkuEFJO1A">USPTO</a>, </span><span class="patent-bibdata-value"><a href="http://www.google.com/url?id=mHNdBAABERAJ&q=http://assignments.uspto.gov/assignments/q%3Fdb%3Dpat%26pat%3D6485982&usg=AFQjCNGjOGuwEpKyCM64UpzId4FJUNpMFA">USPTO Assignment</a>, </span><span class="patent-bibdata-value"><a href="http://www.google.com/url?id=mHNdBAABERAJ&q=http://worldwide.espacenet.com/publicationDetails/biblio%3FCC%3DUS%26NR%3D6485982B1%26KC%3DB1%26FT%3DD&usg=AFQjCNH4gQs51fjLWa5ojD5BW9ofn5ygqg">Espacenet</a></span></span></td></tr><tr class="patent-bibdata-group-spacer"></tr></table><div class="number-and-title"><span class="patent-title"><invention-title mxw-id="PT55020328" lang="EN" load-source="patent-office">Test device and method for colored particle immunoassay</invention-title></span><br><span class="patent-number">US 6485982 B1</span></div><div class="patent-section patent-abstract-section"><div class="patent-section-header"><span class="patent-section-title">Abstract</span></div><div class="patent-text"><abstract mxw-id="PA50415819" lang="EN" load-source="patent-office"> <div class="abstract">Disclosed is a test cell and a method for detection of a preselected ligand in a liquid sample such as a body fluid. The test cell includes an elongate outer casing which houses an interior permeable material capable of transporting an aqueous solution and defining a sample inlet, a test volume, and a reservoir volume. The reservoir volume is disposed in a section of the test cell spaced apart from the inlet and is filled with sorbent material. The reservoir acts to receive liquid transported along a flow path defined by the permeable material and extending from the inlet and through the test volume. In the test volume is a test site which includes a first protein having a binding site specific to a first epitope of the ligand immobilized in fluid communication with the flow path. The test site can be observed through a window of the casing.</div>
  </abstract></div></div><div class="patent-section patent-drawings-section"><div class="patent-section-header"><span class="patent-section-title">Images<span class="patent-section-count">(3)</span></span></div><div class="patent-drawings-body"><div class="patent-drawings-carousel"><div class="drawings"><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/US6485982B1/US06485982-20021126-D00000.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/US6485982B1/US06485982-20021126-D00000.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/US6485982B1/US06485982-20021126-D00001.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/US6485982B1/US06485982-20021126-D00001.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/US6485982B1/US06485982-20021126-D00002.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/US6485982B1/US06485982-20021126-D00002.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div></div></div><div class="patent-drawings-control patent-drawings-prev"><img class="patent-drawings-button-img" alt="Previous page"src="/googlebooks/images/kennedy/page_left.png"width="21" height="21" /></div><div class="patent-drawings-control patent-drawings-next"><img class="patent-drawings-button-img" alt="Next page"src="/googlebooks/images/kennedy/page_right.png"width="21" height="21" /></div></div></div><div class="patent-post-drawings"></div><div class="patent-section patent-claims-section"><div class="patent-section-header"><span class="patent-section-title">Claims<span class="patent-section-count">(38)</span></span></div><div class="patent-text"><div mxw-id="PCLM8397839" lang="EN" load-source="patent-office" class="claims">
    <claim-statement>What is claimed is: </claim-statement> <div class="claim"> <div num="1" id="US-6485982-B1-CLM-00001" class="claim">
      <div class="claim-text">1. A test device for determining an analyte in a liquid sample, the device comprising a permeable material defining at least a first portion and a second portion, the portions being in the same plane so as to permit capillary flow communication with each other</div>
      <div class="claim-text">said first portion being the site for application of the liquid sample, and for a conjugate movably supported therein, wherein said conjugate consists of a binder for the analyte coupled to a colored particle, and </div>
      <div class="claim-text">said second portion being the site for visually determining the presence of the colored particle, said second portion consisting of a binder immobilized therein which specifically binds to the analyte. </div>
    </div>
    </div> <div class="claim"> <div num="2" id="US-6485982-B1-CLM-00002" class="claim">
      <div class="claim-text">2. A method for determining the presence of an analyte in a liquid sample comprising:</div>
      <div class="claim-text">a) adding a liquid sample to a first portion of a test device comprising </div>
      <div class="claim-text">a permeable material defining at least a first portion and a second portion, the portions being in the same plane so as to permit capillary flow communication with each other </div>
      <div class="claim-text">said first portion being the site for application of the liquid sample, and for a conjugate movably supported therein, wherein said conjugate consists of a binder for the analyte coupled to a colored particle, and </div>
      <div class="claim-text">said second portion being the site for visually determining the presence of the colored particle, said second portion consisting of a binder immobilized therein which specifically binds to the analyte; </div>
      <div class="claim-text">b) allowing the liquid sample to flow to the second portion of the permeable material; and </div>
      <div class="claim-text">c) determining the presence of the analyte in the liquid sample by visual inspection of the second portion for color development, wherein the presence of the analyte is indicated by the presence of the colored particles. </div>
    </div>
    </div> <div class="claim"> <div num="3" id="US-6485982-B1-CLM-00003" class="claim">
      <div class="claim-text">3. A test device for detecting an analyte in a liquid sample, the device comprising a permeable material defining at least a first portion and a second portion, the portions being positioned so as to permit capillary flow Communication with each other</div>
      <div class="claim-text">said first portion being the site for application of the liquid sample, and for a conjugate movably supported therein, wherein said conjugate consists of a binder for the analyte coupled to a colored particle, and </div>
      <div class="claim-text">said second portion being the site for visually determining the presence of the colored particle, said second portion consisting of a binder immobilized therein which specifically binds to the analyte. </div>
    </div>
    </div> <div class="claim"> <div num="4" id="US-6485982-B1-CLM-00004" class="claim">
      <div class="claim-text">4. A method for determining the presence of an analyte in a liquid sample comprising:</div>
      <div class="claim-text">a) adding a liquid sample to a first portion of a test device comprising </div>
      <div class="claim-text">a permeable material defining at least a first portion and a second portion, the portions being positioned so as to permit capillary flow communication with each other </div>
      <div class="claim-text">said first portion being the site for application of the liquid sample, and for a conjugate movably supported therein, wherein said conjugate consists of a binder for the analyte coupled to a colored particle, and </div>
      <div class="claim-text">said second portion being the site for visually determining the presence of the colored particle, said second portion consisting of a binder immobilized therein which specifically binds to the analyte; </div>
      <div class="claim-text">b) allowing the liquid sample to flow to the second portion of the permeable material; and </div>
      <div class="claim-text">c) determining the presence of the analyte in the liquid sample by visual inspection of the second portion for color development, wherein the presence of the analyte is indicated by the presence of the colored particles. </div>
    </div>
    </div> <div class="claim"> <div num="5" id="US-6485982-B1-CLM-00005" class="claim">
      <div class="claim-text">5. A test device comprising a conjugate and a test strip;</div>
      <div class="claim-text">the conjugate comprising a first binder for a ligand and a colored particle bound thereto, the conjugate forming a complex with the ligand when present together in liquid; </div>
      <div class="claim-text">the test strip comprising a sorbent material defining a flow path extending from a sample application site to at least a test site, the flow path guiding therealong transport of the conjugate and a liquid suspected to contain a ligand; </div>
      <div class="claim-text">a second binder for capturing the ligand or the complex, the second binder being immobilized at the test site; </div>
      <div class="claim-text">whereby accumulation of colored particles at the test site produces a color visible to the unaided eye indicative of the presence of the ligand in the liquid. </div>
    </div>
    </div> <div class="claim-dependent"> <div num="6" id="US-6485982-B1-CLM-00006" class="claim">
      <div class="claim-text">6. The test device of <claim-ref idref="US-6485982-B1-CLM-00005">claim 5</claim-ref> wherein the conjugate is disposed in the flow path upstream of the test site and is mobilizable along the flow path with passing liquid.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="7" id="US-6485982-B1-CLM-00007" class="claim">
      <div class="claim-text">7. The test device of <claim-ref idref="US-6485982-B1-CLM-00006">claim 6</claim-ref> wherein the conjugate is in dry form.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="8" id="US-6485982-B1-CLM-00008" class="claim">
      <div class="claim-text">8. The test device of <claim-ref idref="US-6485982-B1-CLM-00006">claim 6</claim-ref> wherein the conjugate is transported along the flow path by liquid wicking or wetting through the sorbent material.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="9" id="US-6485982-B1-CLM-00009" class="claim">
      <div class="claim-text">9. The test device of <claim-ref idref="US-6485982-B1-CLM-00005">claim 5</claim-ref> wherein the second binder comprises an immobilized protein.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="10" id="US-6485982-B1-CLM-00010" class="claim">
      <div class="claim-text">10. The test device of <claim-ref idref="US-6485982-B1-CLM-00005">claim 5</claim-ref> wherein the second binder comprises an immobilized antibody to the ligand.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="11" id="US-6485982-B1-CLM-00011" class="claim">
      <div class="claim-text">11. The test device of <claim-ref idref="US-6485982-B1-CLM-00005">claim 5</claim-ref> wherein the first binder comprises a second antibody to the ligand.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="12" id="US-6485982-B1-CLM-00012" class="claim">
      <div class="claim-text">12. The test device of <claim-ref idref="US-6485982-B1-CLM-00005">claim 5</claim-ref> wherein the first binder binds to human chorionic gonadotropin.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="13" id="US-6485982-B1-CLM-00013" class="claim">
      <div class="claim-text">13. The test device of <claim-ref idref="US-6485982-B1-CLM-00005">claim 5</claim-ref> wherein the second binder binds to human chorionic gonadotropin.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="14" id="US-6485982-B1-CLM-00014" class="claim">
      <div class="claim-text">14. The test device of <claim-ref idref="US-6485982-B1-CLM-00005">claim 5</claim-ref> wherein the first binder comprises a monoclonal antibody.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="15" id="US-6485982-B1-CLM-00015" class="claim">
      <div class="claim-text">15. The test device of <claim-ref idref="US-6485982-B1-CLM-00005">claim 5</claim-ref> wherein the colored particle is a metal sol particle.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="16" id="US-6485982-B1-CLM-00016" class="claim">
      <div class="claim-text">16. The test device of <claim-ref idref="US-6485982-B1-CLM-00015">claim 15</claim-ref> wherein the metal sol particle is colloidal gold.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="17" id="US-6485982-B1-CLM-00017" class="claim">
      <div class="claim-text">17. The test device of <claim-ref idref="US-6485982-B1-CLM-00005">claim 5</claim-ref> further comprising a super sorbent material downstream of the test site, the test strip further defining a flow path to the super sorbent material.</div>
    </div>
    </div> <div class="claim"> <div num="18" id="US-6485982-B1-CLM-00018" class="claim">
      <div class="claim-text">18. A method of detecting a ligand in a liquid sample, the method comprising the steps of:</div>
      <div class="claim-text">(a) providing a test device comprising a conjugate and a test strip, </div>
      <div class="claim-text">the conjugate comprising a first binder for a ligand and a colored particle bound thereto, </div>
      <div class="claim-text">the test strip comprising a sorbent material defining a flow path extending from a sample application site to at least a test site, </div>
      <div class="claim-text">a second binder for capturing the ligand or the complex, the second binder being immobilized at the test site; </div>
      <div class="claim-text">(b) applying a liquid sample to the device upstream of the test site so that </div>
      <div class="claim-text">the sample and the conjugate are transported to the test site by liquid wicking or wetting along the flow path, and the conjugate forms a complex with the ligand when present together in the liquid; and </div>
      <div class="claim-text">(c) observing visually the test result at the test site wherein the accumulation of colored particles produces a color indicative of the presence of the ligand in the liquid. </div>
    </div>
    </div> <div class="claim-dependent"> <div num="19" id="US-6485982-B1-CLM-00019" class="claim">
      <div class="claim-text">19. The method of <claim-ref idref="US-6485982-B1-CLM-00018">claim 18</claim-ref>, wherein the conjugate is dried in the flow path upstream of the test site, the liquid sample is applied upstream of the dried conjugate, and the conjugate is mobilized along the flow path by passing liquid.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="20" id="US-6485982-B1-CLM-00020" class="claim">
      <div class="claim-text">20. The method of <claim-ref idref="US-6485982-B1-CLM-00018">claim 18</claim-ref>, comprising the additional step of mixing the conjugate with the liquid sample prior to applying the sample to the test device.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="21" id="US-6485982-B1-CLM-00021" class="claim">
      <div class="claim-text">21. The method of <claim-ref idref="US-6485982-B1-CLM-00020">claim 20</claim-ref>, further comprising the step of allowing liquid to transport the sample and the conjugate to the test site by wicking or wetting along the flow path.</div>
    </div>
    </div> <div class="claim"> <div num="22" id="US-6485982-B1-CLM-00022" class="claim">
      <div class="claim-text">22. An immunoassay method for detecting the presence or concentration of a ligand, the method comprising transporting by wicking or capillary action a liquid suspected to contain the ligand, together with</div>
      <div class="claim-text">a conjugate comprising a colored particulate material bound to a binder for the ligand, the ligand, or an analog of the ligand, </div>
      <div class="claim-text">along a flow path to a test site which binds the ligand or a complex of the ligand, </div>
      <div class="claim-text">thereby to produce a color, visible to the unaided eye, indicative of the presence, absence or concentration of the ligand. </div>
    </div>
    </div> <div class="claim"> <div num="23" id="US-6485982-B1-CLM-00023" class="claim">
      <div class="claim-text">23. A test device comprising a conjugate and a test strip:</div>
      <div class="claim-text">the conjugate comprising a ligand or an analog thereof and a colored particle bound thereto; </div>
      <div class="claim-text">the test strip comprising a sorbent material defining a flow path extending from a sample application site to at least a test site, the flow path guiding transport therealong of the conjugate and of a liquid suspected to contain a ligand; </div>
      <div class="claim-text">a binder for capturing the ligand and the conjugate competitively, the binder being immobilized at the test site; </div>
      <div class="claim-text">whereby accumulation of colored particles at the test site produces a color visible to the unaided eye indicative of the absence of a detectable level of the ligand in the liquid. </div>
    </div>
    </div> <div class="claim-dependent"> <div num="24" id="US-6485982-B1-CLM-00024" class="claim">
      <div class="claim-text">24. The test device of <claim-ref idref="US-6485982-B1-CLM-00023">claim 23</claim-ref> wherein the conjugate is disposed in the flow path upstream of the test site and is mobilizable in the flow path upon passage therealong of liquid.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="25" id="US-6485982-B1-CLM-00025" class="claim">
      <div class="claim-text">25. The test device of <claim-ref idref="US-6485982-B1-CLM-00023">claim 23</claim-ref> wherein the conjugate is in dry form.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="26" id="US-6485982-B1-CLM-00026" class="claim">
      <div class="claim-text">26. The test device of <claim-ref idref="US-6485982-B1-CLM-00023">claim 23</claim-ref> wherein the conjugate is transported along the flow path by liquid wicking or wetting through the sorbent material.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="27" id="US-6485982-B1-CLM-00027" class="claim">
      <div class="claim-text">27. The test device of <claim-ref idref="US-6485982-B1-CLM-00023">claim 23</claim-ref> wherein the colored particle is a metal sol particle.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="28" id="US-6485982-B1-CLM-00028" class="claim">
      <div class="claim-text">28. The test device of <claim-ref idref="US-6485982-B1-CLM-00023">claim 23</claim-ref> wherein the binder comprises an immobilized antibody to the ligand.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="29" id="US-6485982-B1-CLM-00029" class="claim">
      <div class="claim-text">29. The test device of <claim-ref idref="US-6485982-B1-CLM-00023">claim 23</claim-ref> wherein the binder comprises a protein .</div>
    </div>
    </div> <div class="claim-dependent"> <div num="30" id="US-6485982-B1-CLM-00030" class="claim">
      <div class="claim-text">30. The test device of <claim-ref idref="US-6485982-B1-CLM-00023">claim 23</claim-ref> wherein the binder binds to human chorionic gonadotropin.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="31" id="US-6485982-B1-CLM-00031" class="claim">
      <div class="claim-text">31. The test device of <claim-ref idref="US-6485982-B1-CLM-00023">claim 23</claim-ref> wherein the binder comprises a monoclonal antibody.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="32" id="US-6485982-B1-CLM-00032" class="claim">
      <div class="claim-text">32. The test device of <claim-ref idref="US-6485982-B1-CLM-00023">claim 23</claim-ref> wherein the conjugate comprises human chorionic gonadotropin or an analog thereof.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="33" id="US-6485982-B1-CLM-00033" class="claim">
      <div class="claim-text">33. The test device of <claim-ref idref="US-6485982-B1-CLM-00023">claim 23</claim-ref> wherein the conjugate comprises human progesterone or an analog thereof.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="34" id="US-6485982-B1-CLM-00034" class="claim">
      <div class="claim-text">34. The test device of <claim-ref idref="US-6485982-B1-CLM-00023">claim 23</claim-ref> further comprising a super sorbent material downstream of the test site, the test strip further defining a flow path to the super sorbent material.</div>
    </div>
    </div> <div class="claim"> <div num="35" id="US-6485982-B1-CLM-00035" class="claim">
      <div class="claim-text">35. A method of detecting a ligand in a liquid sample, the method comprising the steps of:</div>
      <div class="claim-text">(a) providing a test device comprising a conjugate and a test strip, </div>
      <div class="claim-text">the conjugate comprising a ligand or analog thereof and a colored particle bound thereto, </div>
      <div class="claim-text">the test strip comprising a sorbent material defining a flow path extending from a sample application site to at least a test site, </div>
      <div class="claim-text">a binder for capturing competitively the ligand and the conjugate, the binder being immobilized at the test site; </div>
      <div class="claim-text">(b) applying a liquid sample to the device upstream of the test site so that </div>
      <div class="claim-text">the sample and the conjugate are transported to the test site by liquid wicking or wetting along the flow path; and </div>
      <div class="claim-text">(c) observing visually the test result at the test site wherein the accumulation of colored particles produces a color indicative of the absence of a detectable level of the ligand in the liquid. </div>
    </div>
    </div> <div class="claim-dependent"> <div num="36" id="US-6485982-B1-CLM-00036" class="claim">
      <div class="claim-text">36. The method of <claim-ref idref="US-6485982-B1-CLM-00035">claim 35</claim-ref>, wherein the conjugate is dried in the flow path upstream of the test site, the liquid sample is applied upstream of the dried conjugate, and the conjugate is mobilizable along the flow path by passing liquid.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="37" id="US-6485982-B1-CLM-00037" class="claim">
      <div class="claim-text">37. The method of <claim-ref idref="US-6485982-B1-CLM-00035">claim 35</claim-ref>, further comprising the step of mixing the conjugate with the liquid sample prior to applying the sample to the test device.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="38" id="US-6485982-B1-CLM-00038" class="claim">
      <div class="claim-text">38. The method of <claim-ref idref="US-6485982-B1-CLM-00037">claim 37</claim-ref>, further comprising the step of allowing liquid to transport the sample and the conjugate to the test site by wicking or wetting along the flow path.</div>
    </div>
  </div> </div></div></div><div class="patent-section patent-description-section"><div class="patent-section-header"><span class="patent-section-title">Description</span></div><div class="patent-text"><div mxw-id="PDES53674215" lang="EN" load-source="patent-office" class="description">
    <p>This is a continuation of application(s) Ser. No. 07/995,331 filed Dec. 23, 1992, now U.S. Pat. No. 5,714,389 which is a File Wrapper Continuation of 07/702,450 filed on May 16, 1991, now abandon which is a File Wrapper Continuation of 07/211,582 filed on Jun. 27,1988.</p>
    <heading>BACKGROUND OF THE INVENTION</heading> <p>This invention relates to assays for ligands, e.g., antigens, in a liquid sample such as a body fluid. More particularly, the invention relates to a method and apparatus for the detection of a ligand in a body fluid such as urine using a conjugate comprising colored particles and a novel flow-through test cell.</p>
    <p>Many types of ligand-receptor assays have been used to detect the presence of various substances, often generally called ligands, in body fluids such as urine. These assays involve antigen antibody reactions, synthetic conjugates comprising radioactive, enzymatic, fluorescent, or visually observable metal sol tags, and specially designed reactor chambers. In all these assays, there is a receptor, e.g., an antibody, which is specific for the selected ligand or antigen, and a means for detecting the presence, and often the amount, of the ligand-receptor reaction product. Most current tests are designed to make a quantitative determination, but in many circumstances all that is required is a positive/negative indication. Examples of such qualitative assays include blood typing and most types of urinalysis. For these tests, visually observable indicia such as the presence of agglutination or a color change are preferred.</p>
    <p>Even the positive/negative assays must be very sensitive because of the often small concentration of the ligand of interest in the test fluid. False positives can also be troublesome, particularly with agglutination and other rapid detection methods such as dipstick and color change tests. Because of these problems, sandwich assays and other sensitive detection methods which use metal sols or other types of colored particles have been developed. These techniques have not solved all of the problems encountered in these rapid detection methods.</p>
    <p>It is an object of this invention to provide a rapid, sensitive method for detecting ligands in body fluids. Another object is to provide an assay which has high sensitivity and fewer false positives than conventional assays. A further object is to provide a test cell for detection of low levels of ligands in body fluids. Another object is to provide an assay system which involves a minimal number of procedural steps, and yields reliable results even when used by untrained persons.</p>
    <p>These and other objects and features of the invention will be apparent from the following description, drawings, and claims.</p>
    <heading>SUMMARY OF THE INVENTION</heading> <p>The invention features a method and test cell for the detection of a preselected ligand in a liquid sample such as a body fluid.</p>
    <p>The test cell useful in the practice of the invention has an elongate outer casing which houses an interior permeable material, e.g., glass fiber, capable of transporting an aqueous solution by capillary action, wicking, or simple wetting. The casing defines a sample inlet, and interior regions which, for ease of description, can be designated as a test volume and a reservoir volume. The reservoir volume is disposed in a section of the test cell spaced apart from the inlet, and preferably is filled with sorbent material. The reservoir acts to receive liquid transported along a flow path defined by the permeable material and extending from the inlet and through the test volume. In the test volume is a test site comprising a first protein having a binding site specific to a first epitope of the ligand immobilized in fluid communication with the flow path, e.g., bound to the permeable material or to latex particles entrapped in or bonded to the permeable material. A window such as a hole or transparent section of the casing permits observations of the test site through the casing wall.</p>
    <p>In a preferred embodiment, the flow path is restricted or narrowed in the test area, thereby channeling and concentrating fluid flow into contact with the test site. It is also preferred that the test cell include a solution filtering means disposed in the flow path between the sample inlet and the test site. The filtration means can comprise a separate, conventional filter element disposed within the casing of the test cell in fluid communication with the permeable material defining the flow path, but preferably is defined simply by a portion of the permeable material itself. The provision of such a filtration means in the test cell has the effect of removing by entrapment from impure samples, such as urine samples, a portion of the particulates and nonspecific interfering factors which sometimes cause false positive readings.</p>
    <p>The method of the invention requires the use of a conjugate comprising a second protein bound to colored particles such as a metal sol or colloid, preferably gold. The conjugate can take two distinct forms, depending on whether the assay is designed to exploit the “sandwich” or “competitive” technique.</p>
    <p>In the case of the sandwich technique, the second protein comprises a site which binds to a second epitope on the ligand. This type of conjugate reacts with the ligand to form a complex in the liquid sample. The complex is detected by visual observation of color development at the test site in the test cell. At the test site, the ligand bound with the conjugate reacts with the immobilized first binding protein to form a “sandwich” of the first protein, ligand, second protein, and colored particles. This sandwich complex is progressively produced at the test site as sample continuously passes by, filling the reservoir. As more and more conjugate is immobilized, the colored particles aggregate at the test site and become visible through the window, indicating the presence of ligand in the liquid sample.</p>
    <p>In the case of the competitive technique, the second protein binds with the first protein in competition with the ligand. The second protein comprises, for example, an authentic sample of the ligand or a fraction thereof which has comparable affinity for the first protein. As the liquid sample is transported in contact with the test site, ligand, if any, and the conjugate compete for sites of attachment to the first protein. If no ligand is present, colored particles aggregate at the test site, and the presence of color indicate the absence of detectable levels of ligand in the sample. If ligand is present, the amount of conjugate which binds at the test site is reduced, and no color, or a paler color, develops.</p>
    <p>In one embodiment of the invention, the test liquid is mixed with the conjugate outside the test cell. In another embodiment, the conjugate is disposed in freeze-dried or other preserved form on the permeable material between the inlet and the test site, and the sample liquid resolubilizes the conjugate as it passes along the flow path.</p>
    <p>Color development at the test site may be compared with the color of one or more standards or internal controls to determine whether the development of color is a true indication of the presence or absence of the ligand, or an artifact caused by nonspecific sorption.</p>
    <p>In one embodiment employing the sandwich technique, the standard consists of a negative control site, preferably disposed adjacent the test site, and visible through a second window proximate the first. The negative control site preferably is prepared identically to the test site, except immobilization of the first binding protein is omitted. Therefore, although the conjugate will reach the control site, it aggregates due only to non-specific binding. If the test site is not appreciably more intense in color than the control site, the assay is considered negative.</p>
    <p>In another embodiment, the assay and test cell may include a positive control. Thus, when exploiting the sandwich technique, the cell may have an authentic sample of the ligand immobilized at a control site. If no color develops at this control site, the assay is considered inconclusive. When exploiting the competitive technique, the development of color at the positive control site means the assay results are inconclusive.</p>
    <p>Broadly, the method of the invention involves the use of a test cell of the type described above to achieve an easily readable, sensitive, reproducible indication of the presence of a ligand, e.g., human chorionic gonadotropin (hCG), in a test sample such as a human urine sample. The method involves the step of transporting the sample and a conjugate comprising a protein bound to a metal sol or other colored particle along a flow path and in contact with a test site comprising immobilized binding protein specific to an epitope of the ligand, and preferably also in contact with a control site. Preferably, the colored particle comprises a gold sol; the flow path in the region of the test site is reduced in cross-section relative to other parts of the flow path; the sample is passed through a filtration means after it enters the test cell but before it contacts the test site; and the test site comprises latex particles entrapped or otherwise fixed in the flow path having the immobilized protein on their surface. In the practice of the process, either the conjugate is premixed with the sample, or the conjugate is disposed in preserved form, e.g., lyophilized, in the flow path between the inlet and the test site. In either case, placement of the test cell in the sample, or application of the sample to the inlet, initiates flow, and the result is read by observing color development as the test site, or by comparing the color of the test site and control site.</p>
    <p>The use of the colored particle detection system in combination with the filtration means, the concentrating effect of flow of the sample, and the ease of comparison between the colors of the test and control sites, together enable construction of a family of extremely sensitive assay systems which minimize false positives and can be used effectively by untrained persons.</p>
    <heading>BRIEF DESCRIPTION OF THE DRAWING</heading> <p>FIG. 1 is a cut-away, schematic, top view of an embodiment of a test cell useful in explaining the test cell and process of the invention;</p>
    <p>FIG. 2 is a cross-sectional side view of the test cell of FIG. 1;</p>
    <p>FIG. 3 is a perspective view of a currently preferred test cell constructed in accordance with the invention;</p>
    <p>FIG. 4A is a cross-sectional, top view of the test cell of FIG. 3;</p>
    <p>FIG. 4B is a cross-sectional, side view of the test cell of FIG. 3 taken at line <b>4</b>B—<b>4</b>B of FIG. 4A;</p>
    <p>FIG. 5 is a cross sectional view of the cell of FIG. 3 taken at line <b>5</b>—<b>5</b> of FIG. 4B; and</p>
    <p>FIG. 6 is a perspective view of another embodiment of a test cell constructed in accordance with the invention.</p>
    <p>Like reference characters in the respective drawn figures indicate corresponding parts.</p>
    <heading>DESCRIPTION</heading> <p>The invention provides a test cell for conducting a sandwich or competitive immunoassay, and a process which utilizes the test cell and a conjugate comprising colored particles. As disclosed below, various features of the process and test cell of the invention cooperate to enable untrained personnel reliably to assay a liquid sample for the presence of extremely small quantities of a particular ligand while avoiding false positives and simplifying test procedures. The invention is ideal for use in over-the-counter assay test kits which will enable a consumer to self diagnose, for example, pregnancy, venereal disease, and other disease, infection, or clinical abnormality which results in the presence of an antigenic marker substance in a body fluid, including determination of the presence of metabolites of drugs or toxins. The assay process and the cell are engineered specifically to detect the presence of a preselected individual ligand present in a body or other fluids.</p>
    <p>Broadly, the test cell and process of the invention can be used to detect any ligand which has heretofore been assayed using known immunoassay procedures, or known to be detectable by such procedures, using polyclonal or monoclonal antibodies or other proteins comprising binding sites for ligands. Various specific assay protocols, reagents, and analytes useful in the practice of the invention are known per se, see, e.g., U.S. Pat No. 4,313,734, columns 4-18, and U.S. Pat. No. 4,366,241, columns 5-40.</p>
    <p>The combination of features believed to be responsible for the excellent sensitivity and reproducibility of assays constructed in accordance with the invention is the use of the novel test cell which serves to concentrate ligand from a test sample at a test site in the cell, and the use of a metal sol or other colored particle as a marker system which permits direct visual observation of color development. False positives are reduced while maintaining excellent sensitivity by including in the test cell a negative control or control site whose color is compared with the test site, and by including a filtration means which limits the introduction to the test site of contaminants from the sample.</p>
    <p>The assay is conducted by simply placing the inlet of the test cell in contact with a liquid test sample. One then merely waits for the test sample to pass through the cell and into reactive contact with the test site (and optionally one or more control sites) visible through a window or windows in the cell's exterior casing. In one embodiment, the conjugate is mixed with the sample and incubated briefly before the test cell is inserted. In another embodiment, the conjugate is disposed in preserved form in the flow path within the cell. If the ligand is present in the sample, it passes through the inlet and the interior of the cell along the flow path past the test and control sites, where, in the sandwich embodiment, it reacts with immobilized binding protein, e.g., antibody, at the test site, and perhaps also non-specifically at the control site. A “sandwich” forms at the test site comprising immobilized binding protein-ligand binding protein-colored particle. The presence of the sandwich complex and thus the ligand is indicated by the development of color caused by aggregation of the metal sol particles at the test site. A deeper color at the test site than at the negative control site is a positive indication of the presence of the ligand.</p>
    <p>By providing a reservoir of sorbent material disposed beyond the test and control sites, a relatively large volume of the test liquid and any ligand it contains can be drawn through the test area to aid sensitivity. Optionally, the region of the flow path in the test cell defining the test and control sites is restricted in cross-sectional area relative to other regions of the flow path. This feature produces a “bottle-neck” effect wherein all ligand in the entire volume of sorbed sample must pass through the restricted flow area immediately about the test site where it will be immobilized by reaction with binding protein.</p>
    <p>From the foregoing, it will be apparent that the success of the test procedure is dependent on ligand present in the sample reacting with the conjugate, or on reproducible competition between the ligand and the conjugate for sites of attachment at the test site. In accordance with the invention, as noted above, the assays can be conducted by premixing the conjugate with the liquid sample prior to introduction into the elongate test cell. Alternatively, the conjugate may be disposed in preserved form, e.g., freeze-dried, in the flow path within the test cell upstream of the test and control sites. In this case, the cell is placed directly in the liquid sample solution without premixing. Ligand, if any, passing up through the cell and entrained within the liquid moves into contact with the conjugate forming an immune complex or initiating competition in situ as flow continues. This latter technique has the advantage that it eliminates a manipulative step in the assay procedure, and accordingly a possible source of error.</p>
    <p>Referring to the drawing, FIGS. 1 and 2 illustrate schematically an embodiment of a test cell <b>5</b> constructed in accordance with the invention useful in explaining its principles of construction. It comprises an outer, molded casing <b>10</b> which defines a hollow, elongate enclosure filled with a permeable, sorbent material <b>12</b>. Casing <b>10</b> also defines a test liquid inlet <b>14</b> and a pair of circular openings <b>16</b>, <b>18</b> comprising windows through which sorbent material <b>12</b> is visible.</p>
    <p>Sorbent material <b>12</b> and the interior of casing <b>10</b> together define a flow path passing generally from left to right in FIGS. 1 and 2. When the test cell is placed with inlet <b>14</b> disposed within or otherwise in contact with a liquid sample, the liquid is transported by capillary action, wicking, or simple wetting along the flow path through downstream flow section <b>20</b>, test volume <b>22</b>, and into reservoir volume <b>24</b>, generally as depicted by the arrows. The flow section <b>20</b> of the flow path disposed inwardly of the inlet <b>14</b> serves as a filter which can remove from impure test samples particulate matter and interfering factors. The provisions of such a filtration means <b>20</b> downstream of the inlet <b>14</b> is believed to contribute to the success of the system and its ability to avoid false positives.</p>
    <p>Disposed within sorbent material <b>12</b> is a band <b>26</b> of dehydrated conjugate, e.g., antibody-metal sol. As the liquid sample moves past band <b>26</b>, the conjugate is entrained in the liquid, reconstituted, and reacts or competes with ligand, if present, dissolved in the liquid sample. Of course, conjugate band <b>26</b> may be eliminated, and the conjugate added to the test liquid prior to introduction of the cell <b>5</b> as previously noted.</p>
    <p>Within the volume of sorbent material <b>12</b> disposed directly beneath circular openings <b>16</b> and <b>18</b> in casing <b>10</b> is disposed, respectively, control site <b>16</b>′ and test site <b>18</b>′. In the drawing, the control and test site are illustrated as being disposed serially along the flow path. Alternatively, the control and test site or sites may be disposed side by side or in other spacial relationships.</p>
    <p>Test site <b>18</b>′ comprises a preselected quantity of antibody against an epitope of the ligand to be detected immobilized in place within the flow path. Its detailed chemical structure can vary widely. Control site <b>16</b>′ is preferably identical in size and chemical makeup to test site <b>18</b>′, excepting that the immobilized antibody present at the test site <b>18</b>′ is omitted at the control site <b>16</b>′. Thus, any nonspecific aggregation of, e.g., ligand-conjugate or free conjugate, which occurs at test site <b>18</b>′ also will occur at control site <b>16</b>′. A deeper color at test site <b>18</b>′ as compared with control site <b>16</b>′ is a positive indication of ligand in the sample in the sandwich assay.</p>
    <p>The invention is not limited by the precise nature of the test site <b>18</b>′ and corresponding control site <b>16</b>′, and in fact, control site <b>16</b>′ may be entirely eliminated if a reduction in sensitivity can be tolerated. Generally, antibody or other binding protein may be immobilized at test site <b>18</b>′ using adsorption, absorption, or ionic or covalent coupling, in accordance with methods known per se. A currently preferred formulation for test site <b>18</b>,′ is to immobilize monoclonal antibody against an epitope of the ligand on latex beads, and then to entrap or otherwise link the beads in sorbent material <b>12</b> at region <b>18</b>′. Control site <b>16</b>′ is fabricated identically, except that the latex beads contain non specific immunoglobulin, e.g., immunoglobulin from bleedings from an animal that has not been immunized.</p>
    <p>Disposed beyond test volume <b>22</b> is a reservoir volume <b>24</b> comprising a relatively large mass of sorbent or supersorbent material. The purpose of reservoir volume <b>24</b> is to assure that a reasonably large amount of test liquid is drawn through test volume <b>22</b>. Increasing the volume of reservoir <b>24</b> can have the effect of increasing the sensitivity of the assay procedure, as it results in an increase in the amount of ligand passing through the test area <b>22</b>. Suitable sorbents include commercial materials of the type available, for example, from The Dow Chemical Company of Midland, Mich., and the Chemical division of American Colloid, Arlington Heights, Ill. These materials can absorb many times their weight in water and are commonly used in disposable diapers. They comprise lightly crosslinked polyacrylate salts, typically alkali metal salts.</p>
    <p>Polyclonal antisera and indeed monoclonal antibodies or fractions thereof having specific binding properties and high affinity for virtually any antigenic substance are known and commercially available or can be produced from stable cell lines using well known cell fusion and screening techniques. The literature is replete with protein immobilization protocols. See, for example, Laboratory Techniques in Biochemistry and Molecular Biology, Tijssen, Vol. 15, Practice and Theory of Enzyme immunoassays, chapter 13, The Immobilization of Immunoreactants on Solid Phases, pp. 297-328, and the references cited therein.</p>
    <p>Metal sols and other types of colored particles useful as marker substances in immunoassay procedures are also known per se. See, for example, U.S. Pat. No. 4,313,734, Feb. 2, 1982, to Leuvering, the disclosure of which is incorporated herein by reference. For details and engineering principles involved in the synthesis of colored particle conjugates see Horisberger, Evaluation of Colloidal Gold as a Cytochromic Marker for Transmission and scanning Electron Microscopy, Biol. Cellulaire, 36, 253-258 (1979); Leuvering et al, Sol Particle Immunoassay, J. Immunoassay 1 (1), 77-91 (1980), and Frens, Controlled Nucleation for the Regulation of the Particle Size in Monodisperse Gold Suspensions, Nature, Physical Science, 241, pp. 20-22 (1973).</p>
    <p>The cell can take various forms. It will usually comprise an elongate casing comprising interfitting parts made of polyvinyl chloride, polypropylene, or other thermoplastic resin. Its interior flow path will contain a relatively inert material or a combination of materials suitable for transporting the liquid. In some circumstances it. may be preferable to use a material of higher sorptivity as the reservoir, promoting the flow of liquid, and a different material for remaining portions of the flow path.</p>
    <p>From the foregoing it should be apparent that the advantages in reproducibility, sensitivity, and avoidance of false positives of assay systems constructed in accordance with the invention are traceable to a combination of features of the invention. In use, the test cell of the invention and the metal sol particles used as a marker together cooperate to result in an increase in color intensity progressively as ligand completed with conjugate is trapped at the test site by the immobilized binding protein. This approach can be utilized to design assays and test cells for essentially any antigenic material.</p>
    <p>The invention will be further understood from the following non-limiting examples.</p>
    <heading>EXAMPLE 1</heading> <p>The currently preferred test device embodying the invention is shown in FIGS. 3, <b>4</b>A, <b>4</b>B, and <b>5</b>. A modification of the device depicted in FIG. 3 is shown in FIG. 6, and includes a second control site <b>19</b> in addition to control site <b>16</b>′ and test site <b>18</b>′, as well as a stand <b>21</b> useful for maintaining the test cell in an incline position with the reservoir downhill. When a test sample is applied to inlet <b>14</b>, gravity as well as sorption aids in transporting the sample along the flow path.</p>
    <p>As shown in FIGS. 3, <b>4</b>A, <b>4</b>B, and <b>5</b>, the preferred test cell of the invention differs from the exemplary device discussed above and shown in FIGS. 1 and 2 in certain of its more specific internal features. Specifically, the casing <b>10</b> comprises a pair of interfitting polymeric parts including a U-shaped top part <b>10</b>′ which, when the device is assembled, interfits with lower part <b>10</b>″. Top and bottom parts <b>10</b>′ and <b>10</b>″ may be connected through a hinge region <b>11</b>. The bottom section <b>10</b>″ defines a pair of channels <b>28</b> above which is disposed a strip of glass fiber paper <b>13</b> (available commercially from Eaton Dikeman, Grade <b>111</b>, or Whatman, Grade GFA). Test liquid applied through inlet <b>14</b> soaks along the paper strip <b>13</b> which defines the flow path and a filtering means region 20, as well as a positive control site <b>16</b>′ and test site <b>18</b>′ visible through windows <b>16</b> and <b>18</b> consisting of openings through upper mating member <b>10</b>′. The paper strip <b>13</b> overlaps into reservoir volume <b>24</b>, which is defined by a cavity between the interfitting top and bottom mating members <b>10</b>′ and <b>10</b>′. The cavity in this case is filled with sorbent blotting paper <b>12</b> comprising the sorbent reservoir. A suitable paper is sold as Grade <b>12</b> absorbent paper, a cellulose product available from Schleicher and Schuell. In one preferred embodiment, the dimensions of the glass fiber paper <b>13</b> were approximately one quarter inch by three inches, and those of the absorbent material <b>12</b> approximately two inches by five thirty seconds of an inch on each side. A number of these devices were produced and further treated to adapt them to detect pregnancy by assay of urine.</p>
    <p>Test site <b>18</b>′ in each device was fabricated as a spot within fiber paper <b>13</b> using the following technique. Latex beads available commercially and comprising polystyrene particles 0.3 micron in diameter were passively coated with purified rabbit anti-human chorionic gonadotropin. The polyclonal, antibody was purified using conventional techniques from bleedings of a rabbit previously immunized with human chorionic gonadotropin in a manner know per se. Equal parts of a latex (0.6% by weight) having a continuous phase of glycine buffer, pH=8.3, and a 1 mg/ml antibody solution in the same buffer were mixed and incubated at 37°C. 15 microliters of this solution, comprising approximately 0.6% solids, were added, one drop at a time, to the glass fiber paper <b>13</b> to produce spot <b>18</b>′ after the devices had been assembled. The spots were then allowed to dry at 37° C. The control site <b>16</b>′ was produced identically to the test site disclosed immediately above, excepting that rabbit polyclonal non-immune gamma globulin was used in place of the anti-hCG gamma globulin.</p>
    <p>Metal sol particles were prepared in accordance with the method of Frens, Controlled Nucleation for the Regulation of the Particle Size in Mono Dispersed Gold Solutions (1973), supra. Briefly, the gold sol was prepared by reducing a 4% solution of gold chloride with 1% sodium citrate to produce gold particles of approximately 18 nm in diameter. The particles were made immunochemically reactive by admixture with a monoclonal antibody specific for human chorionic gonadotropin with no detectable cross-reactivity with human leutinizing hormone. The antibody was purchased from Charles River Labs, and is produced using standard techniques including purification from ascites using HPLC ion exchange chromatography. It was added to the gold sol as a 10 ug/ml solution in borate buffer, pH-6. The bound antibody fraction is separated from the free fraction by either density centrifugation or gel filtration chromatography. Additional details of the currently preferred procedure for making the antibody sol conjugate are disclosed by Leuvering et al, J. Immunoassay (1980) supra. Individual batches of the latex and the conjugate are titrated to optimize activity so that a suitable amount of latex is applied to the test site and a suitable amount of conjugate is used in conducting the test.</p>
    <p>Test Protocol</p>
    <p>To a 10×50 mm test tube of lyophilized gold sol antibody conjugate is added 0.5 ml urine sample containing a known quantities of hCG. The samples comprised hCG standards purchased from Sigma Chemical Company diluted in processed, hCG negative urine. The contents of the tube are mixed by shaking in a horizontal motion until the lyophilized antibody is dissolved. The device depicted in FIGS. 3-5 is then inserted into the tube, and the results are read after the entire fluid volume has been absorbed.</p>
    <p>The results of this qualitative procedure follows:</p>
    <p>
      <tables> <table frame="none" colsep="0" rowsep="0" class="description-table"> <tgroup align="left" colsep="0" rowsep="0" cols="3"> <colspec colname="1" colwidth="84pt" align="center"> </colspec> <colspec colname="2" colwidth="42pt" align="center"> </colspec> <colspec colname="3" colwidth="91pt" align="center"> </colspec> <thead> <tr class="description-tr"> <td namest="1" nameend="3" align="center" rowsep="1" class="description-td" colspan="3"> </td>
              </tr> <tr class="description-tr"> <td class="description-td"> </td>
                <td class="description-td">Color of</td>
                <td class="description-td">Color of</td>
              </tr> <tr class="description-tr"> <td class="description-td">mIU hCG</td>
                <td class="description-td">Control Spot</td>
                <td class="description-td">Reagent Spot</td>
              </tr> <tr class="description-tr"> <td namest="1" nameend="3" align="center" rowsep="1" class="description-td" colspan="3"> </td>
              </tr> </thead> <tbody valign="top"> <tr class="description-tr"> <td class="description-td"> </td>
              </tr> </tbody> </tgroup> <tgroup align="left" colsep="0" rowsep="0" cols="3"> <colspec colname="1" colwidth="84pt" align="char" char="."> </colspec> <colspec colname="2" colwidth="42pt" align="center"> </colspec> <colspec colname="3" colwidth="91pt" align="center"> </colspec> <tbody valign="top"> <tr class="description-tr"> <td class="description-td">0</td>
                <td class="description-td">grey</td>
                <td class="description-td">grey</td>
              </tr> <tr class="description-tr"> <td class="description-td">25</td>
                <td class="description-td">grey</td>
                <td class="description-td">pink hue</td>
              </tr> <tr class="description-tr"> <td class="description-td">50</td>
                <td class="description-td">grey</td>
                <td class="description-td">pink</td>
              </tr> <tr class="description-tr"> <td class="description-td">100</td>
                <td class="description-td">grey</td>
                <td class="description-td">rose</td>
              </tr> <tr class="description-tr"> <td class="description-td">150</td>
                <td class="description-td">grey</td>
                <td class="description-td">rose</td>
              </tr> <tr class="description-tr"> <td class="description-td">&gt;150</td>
                <td class="description-td">grey</td>
                <td class="description-td">dark rose</td>
              </tr> <tr class="description-tr"> <td namest="1" nameend="3" align="center" rowsep="1" class="description-td" colspan="3"> </td>
              </tr> </tbody> </tgroup> </table> </tables> </p>
    <p>The pink color clearly visible at 50 mIU of human chorionic gonadotropin means that the test can pregnancy one day after a missed menstrual period. In initial stages of testing, approximately 50 negative samples from various sources have been run with no false positives or even border-line cases. It is anticipated that the commercial device will have less than 1% false positives.</p>
    <p>Non-limiting examples of materials which may be assayed in accordance with the invention in addition to the human chorionic gonadotropin noted above include human leutinizing hormone, progesterone, estrogen, and streptoccous.</p>
    <p>Other embodiments are within the following claims.</p>
    </div></div></div><div class="patent-section patent-tabular-section"><a id="backward-citations"></a><div class="patent-section-header"><span class="patent-section-title">Patent Citations</span></div><table class="patent-data-table"><thead class="patent-data-table-thead"><tr class="patent-data-table"><th class="patent-data-table-th">Cited Patent</th><th class="patent-data-table-th">Filing date</th><th class="patent-data-table-th">Publication date</th><th class="patent-data-table-th">Applicant</th><th class="patent-data-table-th">Title</th></tr></thead><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US3620677">US3620677</a></td><td class="patent-data-table-td patent-date-value">Dec 18, 1961</td><td class="patent-data-table-td patent-date-value">Nov 16, 1971</td><td class="patent-data-table-td ">Miles Lab</td><td class="patent-data-table-td ">Indicating device</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US3811840">US3811840</a></td><td class="patent-data-table-td patent-date-value">Apr 1, 1969</td><td class="patent-data-table-td patent-date-value">May 21, 1974</td><td class="patent-data-table-td ">Miles Lab</td><td class="patent-data-table-td ">Test device for detecting low concentrations of substances in fluids</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US3888629">US3888629</a></td><td class="patent-data-table-td patent-date-value">Sep 8, 1972</td><td class="patent-data-table-td patent-date-value">Jun 10, 1975</td><td class="patent-data-table-td ">Kenneth Dawson Bagshawe</td><td class="patent-data-table-td ">Performance of chemical or biological reactions within an absorbent matrix pad</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4042335">US4042335</a></td><td class="patent-data-table-td patent-date-value">Jun 25, 1976</td><td class="patent-data-table-td patent-date-value">Aug 16, 1977</td><td class="patent-data-table-td ">Eastman Kodak Company</td><td class="patent-data-table-td ">Integral element for analysis of liquids</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4045384">US4045384</a></td><td class="patent-data-table-td patent-date-value">Jul 23, 1976</td><td class="patent-data-table-td patent-date-value">Aug 30, 1977</td><td class="patent-data-table-td ">The Dow Chemical Company</td><td class="patent-data-table-td ">Reacting latex with a carbodiimide and an n-hydroxy compound ion</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4094647">US4094647</a></td><td class="patent-data-table-td patent-date-value">Jul 2, 1976</td><td class="patent-data-table-td patent-date-value">Jun 13, 1978</td><td class="patent-data-table-td ">Thyroid Diagnostics, Inc.</td><td class="patent-data-table-td ">Test device</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4168146">US4168146</a></td><td class="patent-data-table-td patent-date-value">Jan 15, 1976</td><td class="patent-data-table-td patent-date-value">Sep 18, 1979</td><td class="patent-data-table-td ">Ab Kabi</td><td class="patent-data-table-td ">Chromogens, indicators, fluorescence</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4169138">US4169138</a></td><td class="patent-data-table-td patent-date-value">Mar 2, 1977</td><td class="patent-data-table-td patent-date-value">Sep 25, 1979</td><td class="patent-data-table-td ">Pharmacia Diagnostics Ab</td><td class="patent-data-table-td ">Binding onto antigen, then adsorption onto biopolymer coated particles, visible reaction</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4205952">US4205952</a></td><td class="patent-data-table-td patent-date-value">May 10, 1977</td><td class="patent-data-table-td patent-date-value">Jun 3, 1980</td><td class="patent-data-table-td ">Technion Research &amp; Development Foundation Ltd.</td><td class="patent-data-table-td ">Specific binding assay method and reagent means</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4219335">US4219335</a></td><td class="patent-data-table-td patent-date-value">Sep 18, 1978</td><td class="patent-data-table-td patent-date-value">Aug 26, 1980</td><td class="patent-data-table-td ">E. I. Du Pont De Nemours And Company</td><td class="patent-data-table-td ">Immunochemical testing using tagged reagents</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4235601">US4235601</a></td><td class="patent-data-table-td patent-date-value">Jan 12, 1979</td><td class="patent-data-table-td patent-date-value">Nov 25, 1980</td><td class="patent-data-table-td ">Thyroid Diagnostics, Inc.</td><td class="patent-data-table-td ">Test device and method for its use</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4256834">US4256834</a></td><td class="patent-data-table-td patent-date-value">Apr 9, 1979</td><td class="patent-data-table-td patent-date-value">Mar 17, 1981</td><td class="patent-data-table-td ">Syva Company</td><td class="patent-data-table-td ">Repressing the signals produced by unbound labels; sensitivity</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4258001">US4258001</a></td><td class="patent-data-table-td patent-date-value">Dec 27, 1978</td><td class="patent-data-table-td patent-date-value">Mar 24, 1981</td><td class="patent-data-table-td ">Eastman Kodak Company</td><td class="patent-data-table-td ">Including biological fluids</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4294818">US4294818</a></td><td class="patent-data-table-td patent-date-value">Jul 30, 1979</td><td class="patent-data-table-td patent-date-value">Oct 13, 1981</td><td class="patent-data-table-td ">University Patents, Inc.</td><td class="patent-data-table-td ">Methods and materials for detection of multiple sclerosis</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4297344">US4297344</a></td><td class="patent-data-table-td patent-date-value">Apr 23, 1980</td><td class="patent-data-table-td patent-date-value">Oct 27, 1981</td><td class="patent-data-table-td ">Behringwerke Aktiengesellschaft</td><td class="patent-data-table-td ">Blood coagulation factors and process for their manufacture</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4313734">US4313734</a></td><td class="patent-data-table-td patent-date-value">Jul 13, 1979</td><td class="patent-data-table-td patent-date-value">Feb 2, 1982</td><td class="patent-data-table-td ">Akzona Incorporated</td><td class="patent-data-table-td ">Metal sol particle immunoassay</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4348207">US4348207</a></td><td class="patent-data-table-td patent-date-value">Jan 29, 1981</td><td class="patent-data-table-td patent-date-value">Sep 7, 1982</td><td class="patent-data-table-td ">Cooper Laboratories, Inc.</td><td class="patent-data-table-td ">Method and means for determination of pregnancy</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4357142">US4357142</a></td><td class="patent-data-table-td patent-date-value">Jul 18, 1980</td><td class="patent-data-table-td patent-date-value">Nov 2, 1982</td><td class="patent-data-table-td ">Akzona Incorporated</td><td class="patent-data-table-td ">Absorption,bonding</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4361537">US4361537</a></td><td class="patent-data-table-td patent-date-value">Aug 11, 1980</td><td class="patent-data-table-td patent-date-value">Nov 30, 1982</td><td class="patent-data-table-td ">Thyroid Diagnostics, Inc.</td><td class="patent-data-table-td ">Capillary transport strip</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4366241">US4366241</a></td><td class="patent-data-table-td patent-date-value">Aug 7, 1980</td><td class="patent-data-table-td patent-date-value">Dec 28, 1982</td><td class="patent-data-table-td ">Syva Company</td><td class="patent-data-table-td ">Concentrating zone method in heterogeneous immunoassays</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4373932">US4373932</a></td><td class="patent-data-table-td patent-date-value">Jan 2, 1981</td><td class="patent-data-table-td patent-date-value">Feb 15, 1983</td><td class="patent-data-table-td ">Akzona Incorporated</td><td class="patent-data-table-td ">Quantitative and qualitative analysis; complexing</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4376110">US4376110</a></td><td class="patent-data-table-td patent-date-value">Aug 4, 1980</td><td class="patent-data-table-td patent-date-value">Mar 8, 1983</td><td class="patent-data-table-td ">Hybritech, Incorporated</td><td class="patent-data-table-td ">Forming a ternary comples between solid phase antibody, antigen, and lebelled antibody</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4411518">US4411518</a></td><td class="patent-data-table-td patent-date-value">Nov 26, 1979</td><td class="patent-data-table-td patent-date-value">Oct 25, 1983</td><td class="patent-data-table-td ">Gamma Biologicals, Inc.</td><td class="patent-data-table-td ">Apparatus for use in qualitative determination of immunological reactions</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4419453">US4419453</a></td><td class="patent-data-table-td patent-date-value">Sep 30, 1982</td><td class="patent-data-table-td patent-date-value">Dec 6, 1983</td><td class="patent-data-table-td ">The Dow Chemical Company</td><td class="patent-data-table-td ">Immunological agglutination assays with dyed or colored latex and kits</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4434150">US4434150</a></td><td class="patent-data-table-td patent-date-value">Oct 19, 1981</td><td class="patent-data-table-td patent-date-value">Feb 28, 1984</td><td class="patent-data-table-td ">Ortho Diagnostic Systems, Inc.</td><td class="patent-data-table-td ">Immunological reagents employing polymeric backbone possessing reactive functional groups</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4435504">US4435504</a></td><td class="patent-data-table-td patent-date-value">Jul 15, 1982</td><td class="patent-data-table-td patent-date-value">Mar 6, 1984</td><td class="patent-data-table-td ">Syva Company</td><td class="patent-data-table-td ">Immunochromatographic assay with support having bound &quot;MIP&quot; and second enzyme</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4446232">US4446232</a></td><td class="patent-data-table-td patent-date-value">Oct 13, 1981</td><td class="patent-data-table-td patent-date-value">May 1, 1984</td><td class="patent-data-table-td ">Liotta Lance A</td><td class="patent-data-table-td ">Enzyme immunoassay with two-zoned device having bound antigens</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4459358">US4459358</a></td><td class="patent-data-table-td patent-date-value">Dec 29, 1982</td><td class="patent-data-table-td patent-date-value">Jul 10, 1984</td><td class="patent-data-table-td ">Polaroid Corporation</td><td class="patent-data-table-td ">Diffusion, nondiffusing, adjustment, unsulation</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4477575">US4477575</a></td><td class="patent-data-table-td patent-date-value">Aug 4, 1981</td><td class="patent-data-table-td patent-date-value">Oct 16, 1984</td><td class="patent-data-table-td ">Boehringer Mannheim Gmbh</td><td class="patent-data-table-td ">Process and composition for separating plasma or serum from whole blood</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4486530">US4486530</a></td><td class="patent-data-table-td patent-date-value">Jun 24, 1981</td><td class="patent-data-table-td patent-date-value">Dec 4, 1984</td><td class="patent-data-table-td ">Hybritech Incorporated</td><td class="patent-data-table-td ">Immunometric assays using monoclonal antibodies</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4487839">US4487839</a></td><td class="patent-data-table-td patent-date-value">Jan 5, 1983</td><td class="patent-data-table-td patent-date-value">Dec 11, 1984</td><td class="patent-data-table-td ">Ortho Diagnostic Systems Inc.</td><td class="patent-data-table-td ">Fluorescent antigens</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4496654">US4496654</a></td><td class="patent-data-table-td patent-date-value">Apr 8, 1983</td><td class="patent-data-table-td patent-date-value">Jan 29, 1985</td><td class="patent-data-table-td ">Quidel</td><td class="patent-data-table-td ">Bonded to biotinylated antibody</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4503143">US4503143</a></td><td class="patent-data-table-td patent-date-value">Aug 20, 1982</td><td class="patent-data-table-td patent-date-value">Mar 5, 1985</td><td class="patent-data-table-td ">Btc Diagnostics Limited Partnership</td><td class="patent-data-table-td ">Enzyme immunoassay with two-part solution of tetramethylbenzidine as chromogen</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4508829">US4508829</a></td><td class="patent-data-table-td patent-date-value">Aug 18, 1982</td><td class="patent-data-table-td patent-date-value">Apr 2, 1985</td><td class="patent-data-table-td ">Teva Pharmaceutical Industries Ltd.</td><td class="patent-data-table-td ">Contacting urine with lectin substrate capable of binding human chorionic gonadotropin, separating and contacting with color reagent</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4515889">US4515889</a></td><td class="patent-data-table-td patent-date-value">Nov 20, 1981</td><td class="patent-data-table-td patent-date-value">May 7, 1985</td><td class="patent-data-table-td ">Boehringer Mannheim Gmbh</td><td class="patent-data-table-td ">Method for carrying out analytical determinations</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4537861">US4537861</a></td><td class="patent-data-table-td patent-date-value">Feb 3, 1983</td><td class="patent-data-table-td patent-date-value">Aug 27, 1985</td><td class="patent-data-table-td ">Elings Virgil B</td><td class="patent-data-table-td ">Apparatus and method for homogeneous immunoassay</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4552839">US4552839</a></td><td class="patent-data-table-td patent-date-value">Aug 1, 1983</td><td class="patent-data-table-td patent-date-value">Nov 12, 1985</td><td class="patent-data-table-td ">Syntex (U.S.A.) Inc.</td><td class="patent-data-table-td ">Determination of analytes in particle-containing medium</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4590169">US4590169</a></td><td class="patent-data-table-td patent-date-value">Nov 18, 1983</td><td class="patent-data-table-td patent-date-value">May 20, 1986</td><td class="patent-data-table-td ">Beckman Instruments, Inc.</td><td class="patent-data-table-td ">Using a mixture of antibody coated particles</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4594327">US4594327</a></td><td class="patent-data-table-td patent-date-value">Nov 2, 1983</td><td class="patent-data-table-td patent-date-value">Jun 10, 1986</td><td class="patent-data-table-td ">Syntex (U.S.A.) Inc.</td><td class="patent-data-table-td ">Assay method for whole blood samples</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4604364">US4604364</a></td><td class="patent-data-table-td patent-date-value">Apr 21, 1983</td><td class="patent-data-table-td patent-date-value">Aug 5, 1986</td><td class="patent-data-table-td ">Kosak Kenneth M</td><td class="patent-data-table-td ">Bioluminescent tracer composition and method of use in immunoassays</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4623461">US4623461</a></td><td class="patent-data-table-td patent-date-value">May 31, 1985</td><td class="patent-data-table-td patent-date-value">Nov 18, 1986</td><td class="patent-data-table-td ">Murex Corporation</td><td class="patent-data-table-td ">Transverse flow diagnostic device</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4624929">US4624929</a></td><td class="patent-data-table-td patent-date-value">Dec 3, 1984</td><td class="patent-data-table-td patent-date-value">Nov 25, 1986</td><td class="patent-data-table-td ">Syntex (U.S.A.) Inc.</td><td class="patent-data-table-td ">Sample collector and assay device and method for its use</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4632901">US4632901</a></td><td class="patent-data-table-td patent-date-value">May 11, 1984</td><td class="patent-data-table-td patent-date-value">Dec 30, 1986</td><td class="patent-data-table-td ">Hybritech Incorporated</td><td class="patent-data-table-td ">Binding enzyme-labeled antibody to antigen on porous membrane</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4639242">US4639242</a></td><td class="patent-data-table-td patent-date-value">Feb 4, 1985</td><td class="patent-data-table-td patent-date-value">Jan 27, 1987</td><td class="patent-data-table-td ">Babson Arthur L</td><td class="patent-data-table-td ">Vessel and procedure for automated assay</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4639419">US4639419</a></td><td class="patent-data-table-td patent-date-value">Sep 21, 1984</td><td class="patent-data-table-td patent-date-value">Jan 27, 1987</td><td class="patent-data-table-td ">Meloy Laboratories, Inc.</td><td class="patent-data-table-td ">Immunological color change test involving two differently colored reagent spots</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4647544">US4647544</a></td><td class="patent-data-table-td patent-date-value">Jun 25, 1984</td><td class="patent-data-table-td patent-date-value">Mar 3, 1987</td><td class="patent-data-table-td ">Nicoli David F</td><td class="patent-data-table-td ">Immunoassay using optical interference detection</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4654309">US4654309</a></td><td class="patent-data-table-td patent-date-value">Apr 9, 1985</td><td class="patent-data-table-td patent-date-value">Mar 31, 1987</td><td class="patent-data-table-td ">Minnesota Mining And Manufacturing Co.</td><td class="patent-data-table-td ">Test method and article for estimating the concentration of free acid in liquid</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4665034">US4665034</a></td><td class="patent-data-table-td patent-date-value">Nov 15, 1983</td><td class="patent-data-table-td patent-date-value">May 12, 1987</td><td class="patent-data-table-td ">Allelix Inc.</td><td class="patent-data-table-td ">Pregnancy test kit</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4666863">US4666863</a></td><td class="patent-data-table-td patent-date-value">Feb 22, 1984</td><td class="patent-data-table-td patent-date-value">May 19, 1987</td><td class="patent-data-table-td ">Amersham International Plc.</td><td class="patent-data-table-td ">Immunoassay with chromatographic medium and labelled reagent</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4690907">US4690907</a></td><td class="patent-data-table-td patent-date-value">Dec 19, 1984</td><td class="patent-data-table-td patent-date-value">Sep 1, 1987</td><td class="patent-data-table-td ">Daiichi Pure Chemicals Co., Ltd.</td><td class="patent-data-table-td ">Capillary tube immunoassay</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4703017">US4703017</a></td><td class="patent-data-table-td patent-date-value">Feb 14, 1984</td><td class="patent-data-table-td patent-date-value">Oct 27, 1987</td><td class="patent-data-table-td ">Becton Dickinson And Company</td><td class="patent-data-table-td ">Solid phase assay with visual readout</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4740468">US4740468</a></td><td class="patent-data-table-td patent-date-value">Feb 14, 1985</td><td class="patent-data-table-td patent-date-value">Apr 26, 1988</td><td class="patent-data-table-td ">Syntex (U.S.A.) Inc.</td><td class="patent-data-table-td ">Concentrating immunochemical test device and method</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4756828">US4756828</a></td><td class="patent-data-table-td patent-date-value">Apr 12, 1984</td><td class="patent-data-table-td patent-date-value">Jul 12, 1988</td><td class="patent-data-table-td ">Syntex (U.S.A.) Inc.</td><td class="patent-data-table-td ">For immunochromatographic analysis; specific binding pair and enzyme non-diffusively bound to strip</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4757004">US4757004</a></td><td class="patent-data-table-td patent-date-value">Mar 16, 1984</td><td class="patent-data-table-td patent-date-value">Jul 12, 1988</td><td class="patent-data-table-td ">Syntex (U.S.A.) Inc.</td><td class="patent-data-table-td ">Component traverses portion of chromatographic material and longitudinal edge includes means for controlling shape of the front of the traversing component</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4761381">US4761381</a></td><td class="patent-data-table-td patent-date-value">Feb 26, 1987</td><td class="patent-data-table-td patent-date-value">Aug 2, 1988</td><td class="patent-data-table-td ">Miles Inc.</td><td class="patent-data-table-td ">Volume metering capillary gap device for applying a liquid sample onto a reactive surface</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4770853">US4770853</a></td><td class="patent-data-table-td patent-date-value">Dec 3, 1986</td><td class="patent-data-table-td patent-date-value">Sep 13, 1988</td><td class="patent-data-table-td ">New Horizons Diagnostics Corporation</td><td class="patent-data-table-td ">Device for self contained solid phase immunodiffusion assay</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4772550">US4772550</a></td><td class="patent-data-table-td patent-date-value">Feb 10, 1986</td><td class="patent-data-table-td patent-date-value">Sep 20, 1988</td><td class="patent-data-table-td ">Miles Inc.</td><td class="patent-data-table-td ">Immobilization, precipitation, kits, immunoassay</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4774192">US4774192</a></td><td class="patent-data-table-td patent-date-value">Jan 28, 1987</td><td class="patent-data-table-td patent-date-value">Sep 27, 1988</td><td class="patent-data-table-td ">Technimed Corporation</td><td class="patent-data-table-td ">A dry reagent delivery system with membrane having porosity gradient</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4778751">US4778751</a></td><td class="patent-data-table-td patent-date-value">May 12, 1986</td><td class="patent-data-table-td patent-date-value">Oct 18, 1988</td><td class="patent-data-table-td ">Diagnostic Products Corporation</td><td class="patent-data-table-td ">Chemically attached to liquid soluble matrix</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4803170">US4803170</a></td><td class="patent-data-table-td patent-date-value">Dec 24, 1986</td><td class="patent-data-table-td patent-date-value">Feb 7, 1989</td><td class="patent-data-table-td ">Ultra Diagnostics Corporation</td><td class="patent-data-table-td ">Analysis of blood, urine, saliva</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4806311">US4806311</a></td><td class="patent-data-table-td patent-date-value">Aug 28, 1985</td><td class="patent-data-table-td patent-date-value">Feb 21, 1989</td><td class="patent-data-table-td ">Miles Inc.</td><td class="patent-data-table-td ">Multilayer immunoassay test using detectable physical properties</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4806312">US4806312</a></td><td class="patent-data-table-td patent-date-value">Aug 28, 1985</td><td class="patent-data-table-td patent-date-value">Feb 21, 1989</td><td class="patent-data-table-td ">Miles Inc.</td><td class="patent-data-table-td ">Multilayer immunoassay test using detectable chemical properties</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4853335">US4853335</a></td><td class="patent-data-table-td patent-date-value">Sep 28, 1987</td><td class="patent-data-table-td patent-date-value">Aug 1, 1989</td><td class="patent-data-table-td ">Olsen Duane A</td><td class="patent-data-table-td ">Colloidal gold particle concentration immunoassay</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4857453">US4857453</a></td><td class="patent-data-table-td patent-date-value">Apr 7, 1987</td><td class="patent-data-table-td patent-date-value">Aug 15, 1989</td><td class="patent-data-table-td ">Syntex (U.S.A.) Inc.</td><td class="patent-data-table-td ">Immunoassay device</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4859612">US4859612</a></td><td class="patent-data-table-td patent-date-value">Oct 7, 1987</td><td class="patent-data-table-td patent-date-value">Aug 22, 1989</td><td class="patent-data-table-td ">Hygeia Sciences, Inc.</td><td class="patent-data-table-td ">Metal sol capture immunoassay procedure, kit for use therewith and captured metal containing composite</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4861711">US4861711</a></td><td class="patent-data-table-td patent-date-value">Dec 13, 1985</td><td class="patent-data-table-td patent-date-value">Aug 29, 1989</td><td class="patent-data-table-td ">Behringwerke Aktiengesellschaft</td><td class="patent-data-table-td ">Sheet-like diagnostic device</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4868108">US4868108</a></td><td class="patent-data-table-td patent-date-value">Dec 12, 1985</td><td class="patent-data-table-td patent-date-value">Sep 19, 1989</td><td class="patent-data-table-td ">Hygeia Sciences, Incorporated</td><td class="patent-data-table-td ">Multiple-antibody detection of antigen</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4879215">US4879215</a></td><td class="patent-data-table-td patent-date-value">Mar 4, 1988</td><td class="patent-data-table-td patent-date-value">Nov 7, 1989</td><td class="patent-data-table-td ">Syntex (U.S.A.) Inc.</td><td class="patent-data-table-td ">Nondiffusive binding, migration by capillary action</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4883688">US4883688</a></td><td class="patent-data-table-td patent-date-value">Jul 5, 1988</td><td class="patent-data-table-td patent-date-value">Nov 28, 1989</td><td class="patent-data-table-td ">Syntex (U.S.A) Inc.</td><td class="patent-data-table-td ">Treating edge with polymer or cutting edge to a sawtooth shape</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4891313">US4891313</a></td><td class="patent-data-table-td patent-date-value">Jan 21, 1988</td><td class="patent-data-table-td patent-date-value">Jan 2, 1990</td><td class="patent-data-table-td ">Boehringer Manheim Corporation</td><td class="patent-data-table-td ">Method for determination of a component of a sample</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4916056">US4916056</a></td><td class="patent-data-table-td patent-date-value">Mar 28, 1988</td><td class="patent-data-table-td patent-date-value">Apr 10, 1990</td><td class="patent-data-table-td ">Abbott Laboratories</td><td class="patent-data-table-td ">Immunoassay</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4920046">US4920046</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Oct 8, 1987</td><td class="patent-data-table-td patent-date-value">Apr 24, 1990</td><td class="patent-data-table-td ">Becton, Dickinson And Company</td><td class="patent-data-table-td ">Control reagent flow</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4945042">US4945042</a></td><td class="patent-data-table-td patent-date-value">Feb 19, 1988</td><td class="patent-data-table-td patent-date-value">Jul 31, 1990</td><td class="patent-data-table-td ">Boehringer Mannheim Gmbh</td><td class="patent-data-table-td ">Process and reagent for the determination of an antibody</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4954452">US4954452</a></td><td class="patent-data-table-td patent-date-value">Jul 9, 1987</td><td class="patent-data-table-td patent-date-value">Sep 4, 1990</td><td class="patent-data-table-td ">Abbott Laboratories</td><td class="patent-data-table-td ">Non-metal colloidal particle immunoassay</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4956302">US4956302</a></td><td class="patent-data-table-td patent-date-value">May 15, 1989</td><td class="patent-data-table-td patent-date-value">Sep 11, 1990</td><td class="patent-data-table-td ">Abbott Laboratories</td><td class="patent-data-table-td ">Lateral flow chromatographic binding assay device</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4959307">US4959307</a></td><td class="patent-data-table-td patent-date-value">Sep 5, 1986</td><td class="patent-data-table-td patent-date-value">Sep 25, 1990</td><td class="patent-data-table-td ">Syntex (U.S.A.) Inc.</td><td class="patent-data-table-td ">Immunoseparating strip</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4960691">US4960691</a></td><td class="patent-data-table-td patent-date-value">Sep 29, 1986</td><td class="patent-data-table-td patent-date-value">Oct 2, 1990</td><td class="patent-data-table-td ">Abbott Laboratories</td><td class="patent-data-table-td ">Chromatographic test strip for determining ligands or receptors</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4962023">US4962023</a></td><td class="patent-data-table-td patent-date-value">Jun 22, 1987</td><td class="patent-data-table-td patent-date-value">Oct 9, 1990</td><td class="patent-data-table-td ">Louisiana State University, Agricultural And Mechanical College</td><td class="patent-data-table-td ">Single incubation immuno sorbent assay method using particle labels to detect test antigen specific antibodies in presence of other antibodies</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4963468">US4963468</a></td><td class="patent-data-table-td patent-date-value">Feb 12, 1987</td><td class="patent-data-table-td patent-date-value">Oct 16, 1990</td><td class="patent-data-table-td ">Syntex (U.S.A.) Inc.</td><td class="patent-data-table-td ">Immunoseparating strip</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4981785">US4981785</a></td><td class="patent-data-table-td patent-date-value">Jun 6, 1988</td><td class="patent-data-table-td patent-date-value">Jan 1, 1991</td><td class="patent-data-table-td ">Ventrex Laboratories, Inc.</td><td class="patent-data-table-td ">Apparatus and method for performing immunoassays</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4981786">US4981786</a></td><td class="patent-data-table-td patent-date-value">Sep 4, 1987</td><td class="patent-data-table-td patent-date-value">Jan 1, 1991</td><td class="patent-data-table-td ">Syntex (U.S.A.) Inc.</td><td class="patent-data-table-td ">Immunology</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4985204">US4985204</a></td><td class="patent-data-table-td patent-date-value">Feb 23, 1988</td><td class="patent-data-table-td patent-date-value">Jan 15, 1991</td><td class="patent-data-table-td ">Boehringer Mannheim Gmbh</td><td class="patent-data-table-td ">Device for carrying out a heterogeneous reaction</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4999285">US4999285</a></td><td class="patent-data-table-td patent-date-value">Nov 15, 1984</td><td class="patent-data-table-td patent-date-value">Mar 12, 1991</td><td class="patent-data-table-td ">Syntex (U.S.A.) Inc.</td><td class="patent-data-table-td ">Paper strip in a housing, immunoassay</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5006474">US5006474</a></td><td class="patent-data-table-td patent-date-value">Dec 16, 1987</td><td class="patent-data-table-td patent-date-value">Apr 9, 1991</td><td class="patent-data-table-td ">Disease Detection International Inc.</td><td class="patent-data-table-td ">Bi-directional lateral chromatographic test device</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5008080">US5008080</a></td><td class="patent-data-table-td patent-date-value">Feb 6, 1990</td><td class="patent-data-table-td patent-date-value">Apr 16, 1991</td><td class="patent-data-table-td ">Abbott Laboratories</td><td class="patent-data-table-td ">Binding assay for antigens or DNA</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5030558">US5030558</a></td><td class="patent-data-table-td patent-date-value">Nov 7, 1986</td><td class="patent-data-table-td patent-date-value">Jul 9, 1991</td><td class="patent-data-table-td ">Syntex (U.S.A.) Inc.</td><td class="patent-data-table-td ">Qualitative immunochromatographic method and device</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5039607">US5039607</a></td><td class="patent-data-table-td patent-date-value">May 17, 1988</td><td class="patent-data-table-td patent-date-value">Aug 13, 1991</td><td class="patent-data-table-td ">Syntex (U.S.A.) Inc.</td><td class="patent-data-table-td ">Method for immunochromatographic analysis</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5043428">US5043428</a></td><td class="patent-data-table-td patent-date-value">Jun 18, 1990</td><td class="patent-data-table-td patent-date-value">Aug 27, 1991</td><td class="patent-data-table-td ">Behringwerke Aktiengesellschaft</td><td class="patent-data-table-td ">Using carbohydrate anion exchange resin, eluting with calcium ons</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5073484">US5073484</a></td><td class="patent-data-table-td patent-date-value">Feb 23, 1983</td><td class="patent-data-table-td patent-date-value">Dec 17, 1991</td><td class="patent-data-table-td ">Bio-Metric Systems, Inc.</td><td class="patent-data-table-td ">Quantitative analysis apparatus and method</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5075078">US5075078</a></td><td class="patent-data-table-td patent-date-value">Oct 5, 1989</td><td class="patent-data-table-td patent-date-value">Dec 24, 1991</td><td class="patent-data-table-td ">Abbott Laboratories</td><td class="patent-data-table-td ">Self-performing immunochromatographic device</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5085987">US5085987</a></td><td class="patent-data-table-td patent-date-value">Aug 13, 1990</td><td class="patent-data-table-td patent-date-value">Feb 4, 1992</td><td class="patent-data-table-td ">Syntex (U.S.A.) Inc.</td><td class="patent-data-table-td ">Immunoseparating strip</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5085988">US5085988</a></td><td class="patent-data-table-td patent-date-value">Jul 5, 1990</td><td class="patent-data-table-td patent-date-value">Feb 4, 1992</td><td class="patent-data-table-td ">Syntex (U.S.A.) Inc.</td><td class="patent-data-table-td ">Immunoseparating strip</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5120504">US5120504</a></td><td class="patent-data-table-td patent-date-value">Jul 12, 1989</td><td class="patent-data-table-td patent-date-value">Jun 9, 1992</td><td class="patent-data-table-td ">Hybritech Incorporated</td><td class="patent-data-table-td ">Apparatus for immunoassays with vent chennels in the container side wall</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5120643">US5120643</a></td><td class="patent-data-table-td patent-date-value">Jul 13, 1987</td><td class="patent-data-table-td patent-date-value">Jun 9, 1992</td><td class="patent-data-table-td ">Abbott Laboratories</td><td class="patent-data-table-td ">Determination of amount or presence of specific binding materials; high speed</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5141850">US5141850</a></td><td class="patent-data-table-td patent-date-value">Feb 7, 1990</td><td class="patent-data-table-td patent-date-value">Aug 25, 1992</td><td class="patent-data-table-td ">Hygeia Sciences, Inc.</td><td class="patent-data-table-td ">Immunoassay; multizone test strip; diffusion of analyte by capillary action</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5141875">US5141875</a></td><td class="patent-data-table-td patent-date-value">Nov 16, 1990</td><td class="patent-data-table-td patent-date-value">Aug 25, 1992</td><td class="patent-data-table-td ">Environmental Diagnostics, Inc.</td><td class="patent-data-table-td ">Applying specimen to body having wicking characteristics, body having two reagents</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5149622">US5149622</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">May 21, 1990</td><td class="patent-data-table-td patent-date-value">Sep 22, 1992</td><td class="patent-data-table-td ">Abbott Laboratories</td><td class="patent-data-table-td ">Solid phase analytical device and method for using same</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5156952">US5156952</a></td><td class="patent-data-table-td patent-date-value">May 11, 1990</td><td class="patent-data-table-td patent-date-value">Oct 20, 1992</td><td class="patent-data-table-td ">Syntex (U.S.A.) Inc.</td><td class="patent-data-table-td ">Qualitative immunochromatographic method and device</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5160701">US5160701</a></td><td class="patent-data-table-td patent-date-value">Apr 15, 1991</td><td class="patent-data-table-td patent-date-value">Nov 3, 1992</td><td class="patent-data-table-td ">Abbott Laboratories</td><td class="patent-data-table-td ">Enzyme immunoassay</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/USRE30267">USRE30267</a></td><td class="patent-data-table-td patent-date-value">May 18, 1978</td><td class="patent-data-table-td patent-date-value">May 6, 1980</td><td class="patent-data-table-td ">Eastman Kodak Company</td><td class="patent-data-table-td ">Multilayer analytical element</td></tr></table><div class="patent-section-footer">* Cited by examiner</div></div><div class="patent-section patent-tabular-section"><a id="npl-citations"></a><div class="patent-section-header"><span class="patent-section-title">Non-Patent Citations</span></div><table class="patent-data-table"><thead class="patent-data-table-thead"><tr class="patent-data-table"><th colspan="3"class="patent-data-table-th">Reference</th></tr></thead><tr><td class="patent-data-table-td ">1</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">"<a href='http://scholar.google.com/scholar?q="Polar+Bear+Hits+Town%3B+OPUS+Immunoassay+System"'>Polar Bear Hits Town; OPUS Immunoassay System</a>", Diagnostic News, issue 1, Mar. 1992, Behring. pp. 73-75.</td></tr><tr><td class="patent-data-table-td ">2</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">"<a href='http://scholar.google.com/scholar?q="Summary+of+Pregslide+00+see+Test+Specifications"'>Summary of Pregslide 00 see Test Specifications</a>", XII World Congress on Fertility &amp; Sterility, Singapore, 1986.</td></tr><tr><td class="patent-data-table-td ">3</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Baker, T.S., "<a href='http://scholar.google.com/scholar?q="Letter+to+Crawford+G.L.%3A+Clarification+of+Dual+Analyte+Protocols"'>Letter to Crawford G.L.: Clarification of Dual Analyte Protocols</a>". 1983.</td></tr><tr><td class="patent-data-table-td ">4</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Bosch, A.M. G., "<a href='http://scholar.google.com/scholar?q="Enzym-und+Sol+Particle+Immunoassays+f%C3%BCr+Hormone"'>Enzym-und Sol Particle Immunoassays für Hormone</a>", Gynecology and Obstetrics, pp. 509-512; 1987. English summary 1 page.</td></tr><tr><td class="patent-data-table-td ">5</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Brdicka, R., "<a href='http://scholar.google.com/scholar?q="Grundlagen+Der+Physikalischen+Chemie"'>Grundlagen Der Physikalischen Chemie</a>", Ch. X. pp. 774-787; Veb Deutscher Verlag Der Wissenschaften, Berlin (1958). English summary 1 page.</td></tr><tr><td class="patent-data-table-td ">6</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Bredig-Leipzig, "<a href='http://scholar.google.com/scholar?q="Einige+Anwendungen+Des+Elektnschen+Lichtbogens"'>Einige Anwendungen Des Elektnschen Lichtbogens</a>", Zietschrist Für Electrochemie, Heft. 22, pp. 514-515; (1898). English summary 1 page.</td></tr><tr><td class="patent-data-table-td ">7</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Chard, T., "<a href='http://scholar.google.com/scholar?q="Pregnancy+Tests%3A+A+Review"'>Pregnancy Tests: A Review</a>", Human Reproduction, vol. 7, No. 5, pp. 701-710, 1952.</td></tr><tr><td class="patent-data-table-td ">8</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Chemical Abstracts 53: 18745 issued 1959, Werdmann et al., "<a href='http://scholar.google.com/scholar?q="Paper+chromatographic+separation+of+copper+%28II%29%2C+silver+%28I%29%2C+and+gold+%28III%29%2C"'>Paper chromatographic separation of copper (II), silver (I), and gold (III),</a>" Osterr. Chemiker Ztg. 60 : 138-139 (1959).</td></tr><tr><td class="patent-data-table-td ">9</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Chemical Abstracts v 5 p. 3753 issued 1911, Fichter et al., "<a href='http://scholar.google.com/scholar?q="The+capillary+analyses+of+colloidal%2C+solutions%2C"'>The capillary analyses of colloidal, solutions,</a>" Verhandl Naturforsch. Ges. Basel 21 (1910) 1-24.</td></tr><tr><td class="patent-data-table-td ">10</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Chemical Abstracts v 5 p. 3753 issued 1911, Fichter, Z. Chem. Ind. Kolloide, 8 (1911):1-2.</td></tr><tr><td class="patent-data-table-td ">11</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Collins, H.W.P., "<a href='http://scholar.google.com/scholar?q="Alternative+Immunoassays"'>Alternative Immunoassays</a>", Ed. John Wiley &amp; Sons, 1985 pp. 34-57.</td></tr><tr><td class="patent-data-table-td ">12</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Collins, W.P.' Statutory Declaration, In the matter of European Patent Application No. 88303744.2-2116 in the name of Unilever NV, 1992.</td></tr><tr><td class="patent-data-table-td ">13</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Collins, W.P., "<a href='http://scholar.google.com/scholar?q="Statutory+Declaration+No.+2"'>Statutory Declaration No. 2</a>", In the Matter of European Patent Application No. 88303744.2/291,194, In the Name of Unilever NV and Oppositions Thereto, 1995.</td></tr><tr><td class="patent-data-table-td ">14</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Collins, W.P.; "<a href='http://scholar.google.com/scholar?q="Expert+Report"'>Expert Report</a>"; In the High Court of Justice, Chancery Division, Patent Court; Unilever PLC v. Chefaro Proprietaries Ltd., 1994.</td></tr><tr><td class="patent-data-table-td ">15</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Colloidal Metal Marking Reference Book (1984-85), vol. 2, No. 1, pp. 1-44.</td></tr><tr><td class="patent-data-table-td ">16</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">E. Blasius and M. Fischer, Papierchromatographische und papierionophoretische Trennung der Elemente der Reduktiongruppe, 178 Z. Anal. Chem. (1960). pp. 28-33 No English translation.</td></tr><tr><td class="patent-data-table-td ">17</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">E. Blasius and M. Fischer, Papierchromatographische und papierionophoretische Trennung der Platinelemente und des Goldes, 177 Z. Anal. Chem. (1960), pp. 412-420 No English translation.</td></tr><tr><td class="patent-data-table-td ">18</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">F. Goppelstroder, Verhandl 3 Naturforsch. Ges. Basel 268 (1861).</td></tr><tr><td class="patent-data-table-td ">19</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Fichter, et al., Die Kapillaranalyse Kolloidaler Lösungen, 21 Verhandl Naturforsch.Ges.Basel 2-24 (1910). No English translation.</td></tr><tr><td class="patent-data-table-td ">20</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Fichter, Ueber die kapillarelektrische Fällung positiver Kolloide Zeitschrift Für Chemie Und Industrie Der Kolliode 1-2 (1911). No English translation.</td></tr><tr><td class="patent-data-table-td ">21</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Frens, "<a href='http://scholar.google.com/scholar?q="Controlled+Nucleation+for+the+Regulation+of+the+Particle+Size+in+Monodisperse+Gold+Suspensions%2C"'>Controlled Nucleation for the Regulation of the Particle Size in Monodisperse Gold Suspensions,</a>" 241 Nature Physical Science 20-22 (1973).</td></tr><tr><td class="patent-data-table-td ">22</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Giles, A.B., "<a href='http://scholar.google.com/scholar?q="Witness+Statement"'>Witness Statement</a>", In the High Court of Justice, Chancery Division, Patent, Court, Unilever PLC v. Chefaro Proprietaries Ltd.; CH 1993. U. No. 3034; 1994.</td></tr><tr><td class="patent-data-table-td ">23</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Glad, C. et al.; "<a href='http://scholar.google.com/scholar?q="Immunocapillarymigration-A+new+Method+for+Immunochemical+Quantitation"'>Immunocapillarymigration-A new Method for Immunochemical Quantitation</a>", Analytical Biochemistry, 85, 180-187 (1978).</td></tr><tr><td class="patent-data-table-td ">24</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Glad, C. et al.; "<a href='http://scholar.google.com/scholar?q="Immunocapillarymigration%E2%80%94A+new+Method+for+Immunochemical+Quantitation"'>Immunocapillarymigration—A new Method for Immunochemical Quantitation</a>", Analytical Biochemistry, 85, 180-187 (1978).</td></tr><tr><td class="patent-data-table-td ">25</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Greenquist et al., "<a href='http://scholar.google.com/scholar?q="Homogenous+Fluorescent+Immunoassay+with+Dry+Re-agents%2C"'>Homogenous Fluorescent Immunoassay with Dry Re-agents,</a>" Clinical Chemistry, vol. 27, No. 9, 1981 pp. 1614-1617.</td></tr><tr><td class="patent-data-table-td ">26</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Gribnau, et al., Particle-Labelled Immunoassays: A Review, 376 J. of Chromatography Biomedical Applications 175-189 (1986).</td></tr><tr><td class="patent-data-table-td ">27</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">H. Weil, Der Ursprung der Papierchromatographie, 40 Naturwissenschaften (1953), pp. 1-7 No English Translation.</td></tr><tr><td class="patent-data-table-td ">28</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">H. Weil, The Evolution of Paper Chromatography, 132 Kolloid-Z (1953), pp. 149-162.</td></tr><tr><td class="patent-data-table-td ">29</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Heap, R.B., et al., "<a href='http://scholar.google.com/scholar?q="Mechanisms+of+Transfer+of+Steroid+Hormones+and+Growth+Factors+into+Milk"'>Mechanisms of Transfer of Steroid Hormones and Growth Factors into Milk</a>", Endocrinologia Experimentalis, vol. 20, pp 101-118; 1986.</td></tr><tr><td class="patent-data-table-td ">30</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Horisberger, "<a href='http://scholar.google.com/scholar?q="Evaluation+of+Colloidal+Gold+as+a+Cytochromic+Marker+for+Transmission+and+Scanning+Electron+Microscopy%2C"'>Evaluation of Colloidal Gold as a Cytochromic Marker for Transmission and Scanning Electron Microscopy,</a>" 36 Biol. Cellulaire 253-58 (1979).</td></tr><tr><td class="patent-data-table-td ">31</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Hsu, Y.-H. , "<a href='http://scholar.google.com/scholar?q="Immunogold+for+Detection+of+Antigen+on+Nitrocellulose+Paper"'>Immunogold for Detection of Antigen on Nitrocellulose Paper</a>" Anal. Biochem., 142, 221-225, 1984.</td></tr><tr><td class="patent-data-table-td ">32</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">J. Perrin, Mécanisme de L'Electrisation de Contact et Solutions Colloidales, Tome III J. De Chimie Physique 50-160 (1905). No English translation.</td></tr><tr><td class="patent-data-table-td ">33</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">J. Perrin, Mécanisme de L'Electrisation de Contact et Solutions Colloidales, Tome III J. De Chimie Physique 601-51 (1904). No English translation.</td></tr><tr><td class="patent-data-table-td ">34</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Johannsson, A., et al., "<a href='http://scholar.google.com/scholar?q="A+Fast+Highly+Sensitive+Colorimetric+Enzyme+Immunoassay+System+Demonstrating+Benefits+of+Enzyme+Amplifications+in+Clinical+Chemistry"'>A Fast Highly Sensitive Colorimetric Enzyme Immunoassay System Demonstrating Benefits of Enzyme Amplifications in Clinical Chemistry</a>", Clinica Chemica Acta, 148, 119-124, (1985).</td></tr><tr><td class="patent-data-table-td ">35</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Johannsson, A., et al., "<a href='http://scholar.google.com/scholar?q="Enzyme+Amplification+for+Immunoassays+Detection+Limit+of+One+Hundredth+of+an+Attomole"'>Enzyme Amplification for Immunoassays Detection Limit of One Hundredth of an Attomole</a>", J. Immunological Methods, 87 7-11 (1986).</td></tr><tr><td class="patent-data-table-td ">36</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Kronick, M.N., "<a href='http://scholar.google.com/scholar?q="Immunoassay+Techniques+with+Fluorescent+Phycobiliprotein+Conjugates"'>Immunoassay Techniques with Fluorescent Phycobiliprotein Conjugates</a>", Clinical Chemistry, 29/9, 1582-1586, 1983.</td></tr><tr><td class="patent-data-table-td ">37</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Lederer, M., "<a href='http://scholar.google.com/scholar?q="Chromatographic+Properties+of+Two+Gold+Compounds+Used+in+the+Therapy+of+Polyarthritis"'>Chromatographic Properties of Two Gold Compounds Used in the Therapy of Polyarthritis</a>", 153 Journal of Chromatography, 302-304 (1978).</td></tr><tr><td class="patent-data-table-td ">38</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Leuvering, et al, "<a href='http://scholar.google.com/scholar?q="Sol+Particle+Immunoassay+%28SPIA%29%2C"'>Sol Particle Immunoassay (SPIA),</a>" 1 (1) J. Immunoassay 77-91 (1980).</td></tr><tr><td class="patent-data-table-td ">39</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Leuvering, et al., Optimization of a Sandwich Sol Particle Immunoasay for Human Chorionic Gonadotrophin, 62 J. Of Immunological Methods 175-184 (1983).</td></tr><tr><td class="patent-data-table-td ">40</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Lou, et al., One-Step Competitive Immunochromatographic Assay for Semiquantitative Determination of Lipoprotein(a) in Plasma, 39(4) Clin. Chem 619-624 (1993).</td></tr><tr><td class="patent-data-table-td ">41</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Maguire T.A., "<a href='http://scholar.google.com/scholar?q="Pregnancy+and+Ovulation+Testing"'>Pregnancy and Ovulation Testing</a>"; The Pharmaceutical Journal , 531-533, (1989), May 6.</td></tr><tr><td class="patent-data-table-td ">42</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">May, K., "<a href='http://scholar.google.com/scholar?q="Witness+Statement"'>Witness Statement</a>", In the High Court of Justice, Chancery Division, Patent Court, Unilever PLC v. Chefaro Proprietaries Ltd.; 1993.</td></tr><tr><td class="patent-data-table-td ">43</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Moeremans, M., et al., "<a href='http://scholar.google.com/scholar?q="Sensitive+Visualization+of+Antigen-Assays+with+Immunogold+and+Immunogold%2FSilver+Staining"'>Sensitive Visualization of Antigen-Assays with Immunogold and Immunogold/Silver Staining</a>", J. Immunological Methods, 74, pp. 353-360, 1984.</td></tr><tr><td class="patent-data-table-td ">44</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Moss, D.W., et al., "<a href='http://scholar.google.com/scholar?q="An+Enzyme-Amplified+Monoclonal+Immunoenzymometric+Assay+for+Prostatic+Acid+Phosphatase"'>An Enzyme-Amplified Monoclonal Immunoenzymometric Assay for Prostatic Acid Phosphatase</a>", Clinica Chimica Acta, 152, 85-94 (1985).</td></tr><tr><td class="patent-data-table-td ">45</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Puissieux, F et al., "<a href='http://scholar.google.com/scholar?q="Les+Liposomes%3B+Applications+Therapeutiques"'>Les Liposomes; Applications Therapeutiques</a>" Technique et Documentation (Lavoisier) 1985, Ch. 2, p. 48 (French, with translation).</td></tr><tr><td class="patent-data-table-td ">46</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Runge, Die Runft der Farbenbereitung, Farbenchemie (1980). 1-288 No English translation.</td></tr><tr><td class="patent-data-table-td ">47</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Sahlbom, V.N., "<a href='http://scholar.google.com/scholar?q="Kapilaranalyse+Kolloider+L%C3%B6sungen"'>Kapilaranalyse Kolloider Lösungen</a>", 2 Kolloidchemische Beihefte, Band II, Heft 3-4, pp. 79-140, Verlag Von Theodor Steinkopff, Dresden-A (1910-11). No English translation.</td></tr><tr><td class="patent-data-table-td ">48</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Stanley, C.J., "<a href='http://scholar.google.com/scholar?q="Affidavit"'>Affidavit</a>", In the Matter of European Patent No. 291,194 to Unilever, NV and In the Matter of Opposition Thereto, 1994.</td></tr><tr><td class="patent-data-table-td ">49</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Stanley, C.J., "<a href='http://scholar.google.com/scholar?q="Witness+Statement"'>Witness Statement</a>", In the High Court of Justice, Chancery Division, Patent Court Unilever PLC v. Chefaro Proprietaries Ltd., 1994.</td></tr><tr><td class="patent-data-table-td ">50</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Stanley, C.J., et al., "<a href='http://scholar.google.com/scholar?q="Amperometric+Enzyme-Amplified+Immunoassays"'>Amperometric Enzyme-Amplified Immunoassays</a>", J. Immunological Methods, 112, 153-161, 1988.</td></tr><tr><td class="patent-data-table-td ">51</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Stanley, C.J., et al., "<a href='http://scholar.google.com/scholar?q="Enzyme+Amplification+Can+Enhance+Both+the+Speed+and+the+Sensitivity+of+Immunoassays"'>Enzyme Amplification Can Enhance Both the Speed and the Sensitivity of Immunoassays</a>", J. Immunological Methods, 83, 89-95 (1985).</td></tr><tr><td class="patent-data-table-td ">52</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Stanley, C.J., et al., "<a href='http://scholar.google.com/scholar?q="Enzyme+Amplification%3A+A+New+Technique+for+Enhancing+the+Speed+and+Sensitivity+of+Enzyme+Immunoassays"'>Enzyme Amplification: A New Technique for Enhancing the Speed and Sensitivity of Enzyme Immunoassays</a>", I.C.P.R., 44-51; Jul./Aug. 1985.</td></tr><tr><td class="patent-data-table-td ">53</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Stanley, C.J., et al., "<a href='http://scholar.google.com/scholar?q="Enzyme-Amplified+Immunoassays"'>Enzyme-Amplified Immunoassays</a>", J. Pharmaceutical and Biomedical Analysis, vol. 5, No. 8, pp. 811-820, 1987.</td></tr><tr><td class="patent-data-table-td ">54</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Stanley, C.J., et al., "<a href='http://scholar.google.com/scholar?q="Use+of+a+New+and+Rapid+Milk+Progesterone+Assay+to+Monitor+Reproductive+Activity+in+the+Cow"'>Use of a New and Rapid Milk Progesterone Assay to Monitor Reproductive Activity in the Cow</a>", The Veterinarian Record, Jun. 14, 1986, pp. 664-667.</td></tr><tr><td class="patent-data-table-td ">55</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Surek, B. "<a href='http://scholar.google.com/scholar?q="Visualization+of+Antigenic+Proteins+Blotted+onto+Nitrocellulose+Using+The+Immuno-Gold+Staining+%28IGS%29+Method"'>Visualization of Antigenic Proteins Blotted onto Nitrocellulose Using The Immuno-Gold Staining (IGS) Method</a>" Biochemical and Biophysical Research Communications, 121 (1), 284-289, 1984.</td></tr><tr><td class="patent-data-table-td ">56</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Syva, Syntex Company, Product Brochure "<a href='http://scholar.google.com/scholar?q="Acculevel%3B+Acculevel+TDM+Assays"'>Acculevel; Acculevel TDM Assays</a>", pp. 1-6, Sep. 1987.</td></tr><tr><td class="patent-data-table-td ">57</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Tijssen, Laboratory Techniques in Biochemistry and Molecular Biology, vol. 15, "<a href='http://scholar.google.com/scholar?q="Practice+and+Theory+of+Enzyme+Immunoassays%2C"'>Practice and Theory of Enzyme Immunoassays,</a>" Chapter 13-The Immobilization of Immunoreactants on Solid Phases, 297-328.</td></tr><tr><td class="patent-data-table-td ">58</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Tijssen, Laboratory Techniques in Biochemistry and Molecular Biology, vol. 15, "<a href='http://scholar.google.com/scholar?q="Practice+and+Theory+of+Enzyme+Immunoassays%2C"'>Practice and Theory of Enzyme Immunoassays,</a>" Chapter 13—The Immobilization of Immunoreactants on Solid Phases, 297-328.</td></tr><tr><td class="patent-data-table-td ">59</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Unanue, E.R., Benacerraf, B.; "<a href='http://scholar.google.com/scholar?q="Immunfluoreszenz"'>Immunfluoreszenz</a>"; Immunologie, pp. 63-65; Walter de Gruyter, Berlin-New York 1987. English Translation.</td></tr><tr><td class="patent-data-table-td ">60</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Van Hell, H., et al., "<a href='http://scholar.google.com/scholar?q="Particle+Immunoassays"'>Particle Immunoassays</a>"; Alternative Immunoassays, Ch. 4, pp. 40-59; 1985.</td></tr><tr><td class="patent-data-table-td ">61</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Verheijden, P., "<a href='http://scholar.google.com/scholar?q="Witness+Statement"'>Witness Statement</a>", In the High Court of Justice, Chancery Division, Patent Court, Unilever PLC v. Chefaro Proprietaries Ltd., 1994.</td></tr><tr><td class="patent-data-table-td ">62</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Welch, P.G., "<a href='http://scholar.google.com/scholar?q="Witness+Statement"'>Witness Statement</a>", In the High Court of Justice, Chancery Division, Patent Court; Unilever PLC v. Chefaro Proprietaries Ltd.; 1994.</td></tr><tr><td class="patent-data-table-td ">63</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Wiberg, E., "<a href='http://scholar.google.com/scholar?q="Lehrbuch+Der+Anorganischen+Chemie"'>Lehrbuch Der Anorganischen Chemie</a>", pp. 333-338, Walter De Gruyte &amp; Co., Berlin, 1960. 1 page English Summary.</td></tr><tr><td class="patent-data-table-td ">64</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Worsfold, A.I., et al., "<a href='http://scholar.google.com/scholar?q="The+Evaluation+of+a+New+Rapid+Milk+Progesterone+Test+as+an+Aid+to+Improving+Dairy+Herd+Fertility"'>The Evaluation of a New Rapid Milk Progesterone Test as an Aid to Improving Dairy Herd Fertility</a>", British Veterinary Journal, 143, 83-87, 1987.</td></tr><tr><td class="patent-data-table-td ">65</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Wright, J.F.; "<a href='http://scholar.google.com/scholar?q="A+Simple+Immunodiagnostic+Test+System+for+Alternate+Site+Market"'>A Simple Immunodiagnostic Test System for Alternate Site Market</a>"; World Biotech Report, pp. 263-271; 1988.</td></tr><tr><td class="patent-data-table-td ">66</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Zsigmondy, R.; "<a href='http://scholar.google.com/scholar?q="Ueber+Wassrige+L%C3%B6sungen+Metallischer+Goldes"'>Ueber Wassrige Lösungen Metallischer Goldes</a>", Annalen Der Chemie, 301, pp. 29-54; 1898. English Translation by Morgan C. Larkin.</td></tr><tr><td class="patent-data-table-td ">67</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Zuk, R.F., et al., Enzyme Immunochromatography-A Quantitative Immunoassay Requiring No Instrumentation, Clinical Chemistry, vol. 31, No. 7, pp. 1145-1150 (1985).</td></tr><tr><td class="patent-data-table-td ">68</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Zuk, R.F., et al., Enzyme Immunochromatography—A Quantitative Immunoassay Requiring No Instrumentation, Clinical Chemistry, vol. 31, No. 7, pp. 1145-1150 (1985).</td></tr></table><div class="patent-section-footer"></div></div><div class="patent-section patent-tabular-section"><a id="forward-citations"></a><div class="patent-section-header"><span class="patent-section-title">Referenced by</span></div><table class="patent-data-table"><thead class="patent-data-table-thead"><tr class="patent-data-table"><th class="patent-data-table-th">Citing Patent</th><th class="patent-data-table-th">Filing date</th><th class="patent-data-table-th">Publication date</th><th class="patent-data-table-th">Applicant</th><th class="patent-data-table-th">Title</th></tr></thead><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7192555">US7192555</a></td><td class="patent-data-table-td patent-date-value">Oct 11, 2001</td><td class="patent-data-table-td patent-date-value">Mar 20, 2007</td><td class="patent-data-table-td ">Orasure Technologies, Inc.</td><td class="patent-data-table-td ">Device for collection and assay of oral fluids</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7241417">US7241417</a></td><td class="patent-data-table-td patent-date-value">Jul 26, 2005</td><td class="patent-data-table-td patent-date-value">Jul 10, 2007</td><td class="patent-data-table-td ">Savyon Diagnostics Ltd.</td><td class="patent-data-table-td ">Assay device</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7332283">US7332283</a></td><td class="patent-data-table-td patent-date-value">Mar 16, 2005</td><td class="patent-data-table-td patent-date-value">Feb 19, 2008</td><td class="patent-data-table-td ">The Board Of Trustees Of The University Of Illinois</td><td class="patent-data-table-td ">Fluorescence based biosensor</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7378285">US7378285</a></td><td class="patent-data-table-td patent-date-value">Sep 22, 2004</td><td class="patent-data-table-td patent-date-value">May 27, 2008</td><td class="patent-data-table-td ">Paul Lambotte</td><td class="patent-data-table-td ">Devices for the detection of multiple analytes in a sample</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7387890">US7387890</a></td><td class="patent-data-table-td patent-date-value">Dec 16, 2004</td><td class="patent-data-table-td patent-date-value">Jun 17, 2008</td><td class="patent-data-table-td ">Chembio Diagnostic Systems, Inc.</td><td class="patent-data-table-td ">chromatographic quick test strips for detection of a ligand in a body fluid; does not require migration of analytes</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7393697">US7393697</a></td><td class="patent-data-table-td patent-date-value">Jun 6, 2003</td><td class="patent-data-table-td patent-date-value">Jul 1, 2008</td><td class="patent-data-table-td ">Advantage Diagnostics Corporation</td><td class="patent-data-table-td ">Diagnostic test for analytes in a sample</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7459314">US7459314</a></td><td class="patent-data-table-td patent-date-value">Feb 10, 2004</td><td class="patent-data-table-td patent-date-value">Dec 2, 2008</td><td class="patent-data-table-td ">Inverness Medical Switzerland Gmbh</td><td class="patent-data-table-td ">Lateral flow immunoassay controls</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7465587">US7465587</a></td><td class="patent-data-table-td patent-date-value">Dec 3, 2004</td><td class="patent-data-table-td patent-date-value">Dec 16, 2008</td><td class="patent-data-table-td ">Genzyme Corporation</td><td class="patent-data-table-td ">detection of a ligand in a body fluid such as urine or blood, which includes an immobilization zone for interfering agents in a sample</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7473563">US7473563</a></td><td class="patent-data-table-td patent-date-value">Apr 3, 2006</td><td class="patent-data-table-td patent-date-value">Jan 6, 2009</td><td class="patent-data-table-td ">The Clorox Company</td><td class="patent-data-table-td ">Simple, versatile, disposable colorimetric sample collection from environmental surfaces and, the sensitive and semi-quantifiable analysis of the sample for specific proteins, detection of specific allergens, viruses, bacteria</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7485419">US7485419</a></td><td class="patent-data-table-td patent-date-value">Jan 13, 2004</td><td class="patent-data-table-td patent-date-value">Feb 3, 2009</td><td class="patent-data-table-td ">The Board Of Trustees Of The University Of Illinois</td><td class="patent-data-table-td ">Biosensors based on directed assembly of particles</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7527981">US7527981</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">May 6, 2003</td><td class="patent-data-table-td patent-date-value">May 5, 2009</td><td class="patent-data-table-td ">Dennis Farwell</td><td class="patent-data-table-td ">Bioweapon-detecting fibrous-network products and methods for making same</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7534560">US7534560</a></td><td class="patent-data-table-td patent-date-value">May 10, 2002</td><td class="patent-data-table-td patent-date-value">May 19, 2009</td><td class="patent-data-table-td ">The Board Of Trustees Of The University Of Illinois</td><td class="patent-data-table-td ">Simple catalytic DNA biosensors for ions based on color changes</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7541194">US7541194</a></td><td class="patent-data-table-td patent-date-value">Jan 17, 2007</td><td class="patent-data-table-td patent-date-value">Jun 2, 2009</td><td class="patent-data-table-td ">Orasure Technologies, Inc.</td><td class="patent-data-table-td ">Device for collection and assay of oral fluids</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7547557">US7547557</a></td><td class="patent-data-table-td patent-date-value">Jun 13, 2006</td><td class="patent-data-table-td patent-date-value">Jun 16, 2009</td><td class="patent-data-table-td ">Quantum Design, Inc.</td><td class="patent-data-table-td ">Directed-flow assay device</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7569397">US7569397</a></td><td class="patent-data-table-td patent-date-value">Jun 13, 2008</td><td class="patent-data-table-td patent-date-value">Aug 4, 2009</td><td class="patent-data-table-td ">Chembio Diagnostic Systems, Inc.</td><td class="patent-data-table-td ">Immunoassay devices and use thereof</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7612185">US7612185</a></td><td class="patent-data-table-td patent-date-value">Mar 7, 2003</td><td class="patent-data-table-td patent-date-value">Nov 3, 2009</td><td class="patent-data-table-td ">The Board Of Trustees Of The University Of Illinois</td><td class="patent-data-table-td ">Nucleic acid biosensors</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7629127">US7629127</a></td><td class="patent-data-table-td patent-date-value">Jan 21, 2005</td><td class="patent-data-table-td patent-date-value">Dec 8, 2009</td><td class="patent-data-table-td ">Dexall Biomedical Labs, Inc.</td><td class="patent-data-table-td ">immunoassay; colorimetric analysis; biochemical immobilization; using testing strip to detect allergies; improves accuracy and readability</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7632687">US7632687</a></td><td class="patent-data-table-td patent-date-value">Mar 23, 2005</td><td class="patent-data-table-td patent-date-value">Dec 15, 2009</td><td class="patent-data-table-td ">Quidel Corporation</td><td class="patent-data-table-td ">Hybrid phase lateral flow assay</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7691644">US7691644</a></td><td class="patent-data-table-td patent-date-value">May 5, 2008</td><td class="patent-data-table-td patent-date-value">Apr 6, 2010</td><td class="patent-data-table-td ">Quidel Corporation</td><td class="patent-data-table-td ">Microfluidic apparatus comprising a matrix defining an axial flow path; for use in detection of preferential biopolymers in solution; high throughput assay</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7709272">US7709272</a></td><td class="patent-data-table-td patent-date-value">Aug 12, 2003</td><td class="patent-data-table-td patent-date-value">May 4, 2010</td><td class="patent-data-table-td ">N-Dia, Inc.</td><td class="patent-data-table-td ">Devices and methods for detecting amniotic fluid in vaginal secretions</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7723124">US7723124</a></td><td class="patent-data-table-td patent-date-value">Feb 9, 2005</td><td class="patent-data-table-td patent-date-value">May 25, 2010</td><td class="patent-data-table-td ">Rapid Pathogen Screening, Inc.</td><td class="patent-data-table-td ">Using swab for non-invasive recovery of bodily fluids for enzymatic and or immunochemical detection of pathogens</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7776618">US7776618</a></td><td class="patent-data-table-td patent-date-value">Mar 1, 2007</td><td class="patent-data-table-td patent-date-value">Aug 17, 2010</td><td class="patent-data-table-td ">Church &amp; Dwight Co., Inc.</td><td class="patent-data-table-td ">Apparatus comprising biphasic substrate comprised of colloidal gold particles conjugated to streptavidin for use in detection of human chorionic gonadotropin (hCG); pregnancy test</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7780915">US7780915</a></td><td class="patent-data-table-td patent-date-value">Feb 15, 2006</td><td class="patent-data-table-td patent-date-value">Aug 24, 2010</td><td class="patent-data-table-td ">Epitope Diagnostcs, Inc.</td><td class="patent-data-table-td ">Fecal sample test device and methods of use</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7790439">US7790439</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Aug 9, 2002</td><td class="patent-data-table-td patent-date-value">Sep 7, 2010</td><td class="patent-data-table-td ">Panasonic Corporation</td><td class="patent-data-table-td ">For detection of concentration in solutions; immunochromatography</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7794656">US7794656</a></td><td class="patent-data-table-td patent-date-value">Apr 25, 2008</td><td class="patent-data-table-td patent-date-value">Sep 14, 2010</td><td class="patent-data-table-td ">Quidel Corporation</td><td class="patent-data-table-td ">Quantitative/qualitative analyzers for solid, semisolid, or liquid biological samples using a lateral flow assay test strip for minimization of sample handling, manipulation upon introducing sample into receiving chamber, mixing with a buffer, and transferring to a test chamber; kits; food, soils</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7799554">US7799554</a></td><td class="patent-data-table-td patent-date-value">Mar 15, 2007</td><td class="patent-data-table-td patent-date-value">Sep 21, 2010</td><td class="patent-data-table-td ">The Board Of Trustees Of The University Of Illinois</td><td class="patent-data-table-td ">An analytical test for an analyte comprises a base with a reaction area and a visualization area, a capture species on the base in the visualization area comprising nucleic acid, and analysis chemistry reagents on the base in the reaction area</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7871568">US7871568</a></td><td class="patent-data-table-td patent-date-value">Jan 22, 2007</td><td class="patent-data-table-td patent-date-value">Jan 18, 2011</td><td class="patent-data-table-td ">Quidel Corporation</td><td class="patent-data-table-td ">test assemblies that may be used for rapid testing of solid, semi-solid, or liquid specimens; for testing the presence of fecal occult blood, urine, saliva</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7871781">US7871781</a></td><td class="patent-data-table-td patent-date-value">May 23, 2006</td><td class="patent-data-table-td patent-date-value">Jan 18, 2011</td><td class="patent-data-table-td ">Phadia Ab</td><td class="patent-data-table-td ">immobilized immunoglobulins, antibodies</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7883899">US7883899</a></td><td class="patent-data-table-td patent-date-value">Oct 8, 2003</td><td class="patent-data-table-td patent-date-value">Feb 8, 2011</td><td class="patent-data-table-td ">Zbx Corporation</td><td class="patent-data-table-td ">for rapid and efficient immunochromatic determination of one or more components in fluid samples; useful for identifying analytes in small volumes of whole blood samples utilizing one membrane principally for separating particles such as red blood cells from plasma and a second membrane</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7892734">US7892734</a></td><td class="patent-data-table-td patent-date-value">Aug 11, 2005</td><td class="patent-data-table-td patent-date-value">Feb 22, 2011</td><td class="patent-data-table-td ">The Board Of Trustees Of The University Of Illinois</td><td class="patent-data-table-td ">Aptamer based colorimetric sensor systems</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7902353">US7902353</a></td><td class="patent-data-table-td patent-date-value">Feb 12, 2007</td><td class="patent-data-table-td patent-date-value">Mar 8, 2011</td><td class="patent-data-table-td ">The Board Of Trustees Of The University Of Illinois</td><td class="patent-data-table-td ">Using ribozymes as signal transducers for ion detection; pollution control and bioremediation; soil screening of metals</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7906320">US7906320</a></td><td class="patent-data-table-td patent-date-value">Sep 9, 2008</td><td class="patent-data-table-td patent-date-value">Mar 15, 2011</td><td class="patent-data-table-td ">The Board Of Trustees Of The University Of Illinois</td><td class="patent-data-table-td ">Fluorescence based biosensor</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7932099">US7932099</a></td><td class="patent-data-table-td patent-date-value">Feb 21, 2007</td><td class="patent-data-table-td patent-date-value">Apr 26, 2011</td><td class="patent-data-table-td ">Nexus Dx, Inc.</td><td class="patent-data-table-td ">Lateral flow device comprising bibulous strip containing one or more discrete bands of pRNA non-diffusively bound to support, each band capable of indirectly capturing different analyte with high specificity; screening for pathogenic virus, enzymes and/or proteins</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7968348">US7968348</a></td><td class="patent-data-table-td patent-date-value">Nov 20, 2008</td><td class="patent-data-table-td patent-date-value">Jun 28, 2011</td><td class="patent-data-table-td ">The Clorox Company</td><td class="patent-data-table-td ">Environmental sampling and testing method</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8043802">US8043802</a></td><td class="patent-data-table-td patent-date-value">Oct 29, 2007</td><td class="patent-data-table-td patent-date-value">Oct 25, 2011</td><td class="patent-data-table-td ">The Board Of Trustees Of The University Of Illinois</td><td class="patent-data-table-td ">Fluorescence based biosensor</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8053203">US8053203</a></td><td class="patent-data-table-td patent-date-value">Oct 30, 2007</td><td class="patent-data-table-td patent-date-value">Nov 8, 2011</td><td class="patent-data-table-td ">John Wan</td><td class="patent-data-table-td ">Methods and device for the detection of occult blood</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8058415">US8058415</a></td><td class="patent-data-table-td patent-date-value">Apr 24, 2008</td><td class="patent-data-table-td patent-date-value">Nov 15, 2011</td><td class="patent-data-table-td ">The Board Of Trustees Of The University Of Illinois</td><td class="patent-data-table-td ">Aptamer- and nucleic acid enzyme-based systems for simultaneous detection of multiple analytes</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8062893">US8062893</a></td><td class="patent-data-table-td patent-date-value">Sep 22, 2009</td><td class="patent-data-table-td patent-date-value">Nov 22, 2011</td><td class="patent-data-table-td ">The Board Of Trustees Of The University Of Illinois</td><td class="patent-data-table-td ">Fluorescent sensor for mercury</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8062908">US8062908</a></td><td class="patent-data-table-td patent-date-value">Jan 8, 2009</td><td class="patent-data-table-td patent-date-value">Nov 22, 2011</td><td class="patent-data-table-td ">Orasure Technologies, Inc.</td><td class="patent-data-table-td ">Device for collection and assay of oral fluids</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8084276">US8084276</a></td><td class="patent-data-table-td patent-date-value">Oct 28, 2010</td><td class="patent-data-table-td patent-date-value">Dec 27, 2011</td><td class="patent-data-table-td ">Universiteit Maastricht</td><td class="patent-data-table-td ">Method for identifying a subject at risk of developing heart failure by determining the level of galectin-3 or thrombospondin-2</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8114610">US8114610</a></td><td class="patent-data-table-td patent-date-value">Mar 11, 2010</td><td class="patent-data-table-td patent-date-value">Feb 14, 2012</td><td class="patent-data-table-td ">N-Dia, Inc.</td><td class="patent-data-table-td ">Devices and methods for detecting amniotic fluid in vaginal secretions</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8118740">US8118740</a></td><td class="patent-data-table-td patent-date-value">Jun 30, 2006</td><td class="patent-data-table-td patent-date-value">Feb 21, 2012</td><td class="patent-data-table-td ">Ipventure, Inc.</td><td class="patent-data-table-td ">Moisture sensor for skin</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8193002">US8193002</a></td><td class="patent-data-table-td patent-date-value">Oct 30, 2008</td><td class="patent-data-table-td patent-date-value">Jun 5, 2012</td><td class="patent-data-table-td ">Alere Switzerland Gmbh</td><td class="patent-data-table-td ">Lateral flow immunoassay controls</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8202217">US8202217</a></td><td class="patent-data-table-td patent-date-value">Jun 12, 2006</td><td class="patent-data-table-td patent-date-value">Jun 19, 2012</td><td class="patent-data-table-td ">Ip Venture, Inc.</td><td class="patent-data-table-td ">Healthcare base</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8206915">US8206915</a></td><td class="patent-data-table-td patent-date-value">Jan 31, 2011</td><td class="patent-data-table-td patent-date-value">Jun 26, 2012</td><td class="patent-data-table-td ">Board Of Trustees Of The University Of Illinois</td><td class="patent-data-table-td ">Nucleic acid enzyme biosensors for ions</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8211711">US8211711</a></td><td class="patent-data-table-td patent-date-value">Jun 25, 2010</td><td class="patent-data-table-td patent-date-value">Jul 3, 2012</td><td class="patent-data-table-td ">Church &amp; Dwight Co., Inc.</td><td class="patent-data-table-td ">Diagnostic detection device</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8268636">US8268636</a></td><td class="patent-data-table-td patent-date-value">Jun 25, 2010</td><td class="patent-data-table-td patent-date-value">Sep 18, 2012</td><td class="patent-data-table-td ">Church &amp; Dwight Co., Inc.</td><td class="patent-data-table-td ">Diagnostic detection device</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8326412">US8326412</a></td><td class="patent-data-table-td patent-date-value">Sep 30, 2011</td><td class="patent-data-table-td patent-date-value">Dec 4, 2012</td><td class="patent-data-table-td ">Hydradx, Inc.</td><td class="patent-data-table-td ">Diagnostic device and method for sensing hydration state of a mammalian subject</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8349573">US8349573</a></td><td class="patent-data-table-td patent-date-value">Aug 31, 2011</td><td class="patent-data-table-td patent-date-value">Jan 8, 2013</td><td class="patent-data-table-td ">John Wan</td><td class="patent-data-table-td ">Methods and device for the detection of occult blood</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8349618">US8349618</a></td><td class="patent-data-table-td patent-date-value">Nov 23, 2010</td><td class="patent-data-table-td patent-date-value">Jan 8, 2013</td><td class="patent-data-table-td ">Zbx Corporation</td><td class="patent-data-table-td ">Diagnostic devices</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8367416">US8367416</a></td><td class="patent-data-table-td patent-date-value">Aug 6, 2008</td><td class="patent-data-table-td patent-date-value">Feb 5, 2013</td><td class="patent-data-table-td ">The Board Of Trustees Of The University Of Illinois</td><td class="patent-data-table-td ">Nucleic acid based fluorescent sensor for mercury detection</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8399261">US8399261</a></td><td class="patent-data-table-td patent-date-value">Jun 27, 2008</td><td class="patent-data-table-td patent-date-value">Mar 19, 2013</td><td class="patent-data-table-td ">Inbios International, Inc.</td><td class="patent-data-table-td ">Lateral flow assay system and methods for its use</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8409800">US8409800</a></td><td class="patent-data-table-td patent-date-value">Jul 16, 2008</td><td class="patent-data-table-td patent-date-value">Apr 2, 2013</td><td class="patent-data-table-td ">The Board Of Trustees Of The University Of Illinois</td><td class="patent-data-table-td ">Nucleic acid based fluorescent sensor for copper detection</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8415461">US8415461</a></td><td class="patent-data-table-td patent-date-value">Jan 16, 2008</td><td class="patent-data-table-td patent-date-value">Apr 9, 2013</td><td class="patent-data-table-td ">The Board Of Trustees Of The University Of Illinois</td><td class="patent-data-table-td ">Amphiphilic substances and functionalized lipid vesicles including the same</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8445293">US8445293</a></td><td class="patent-data-table-td patent-date-value">Sep 29, 2009</td><td class="patent-data-table-td patent-date-value">May 21, 2013</td><td class="patent-data-table-td ">Rapid Pathogen Screening, Inc.</td><td class="patent-data-table-td ">Method to increase specificity and/or accuracy of lateral flow immunoassays</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8470532">US8470532</a></td><td class="patent-data-table-td patent-date-value">Jan 18, 2011</td><td class="patent-data-table-td patent-date-value">Jun 25, 2013</td><td class="patent-data-table-td ">The Board Of Trustees Of The University Of Illinois</td><td class="patent-data-table-td ">Aptamer-based colorimetric sensor systems</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8486717">US8486717</a></td><td class="patent-data-table-td patent-date-value">Jan 4, 2012</td><td class="patent-data-table-td patent-date-value">Jul 16, 2013</td><td class="patent-data-table-td ">Symbolics, Llc</td><td class="patent-data-table-td ">Lateral flow assays using two dimensional features</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8507295">US8507295</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Nov 10, 2008</td><td class="patent-data-table-td patent-date-value">Aug 13, 2013</td><td class="patent-data-table-td ">Nigel Robert Caterer</td><td class="patent-data-table-td ">Methods of quantification for lateral flow devices</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8568690">US8568690</a></td><td class="patent-data-table-td patent-date-value">Jul 29, 2008</td><td class="patent-data-table-td patent-date-value">Oct 29, 2013</td><td class="patent-data-table-td ">The Board Of Trustees Of The University Of Illinois</td><td class="patent-data-table-td ">MRI contrast agents and high-throughput screening by MRI</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8611992">US8611992</a></td><td class="patent-data-table-td patent-date-value">Jul 3, 2012</td><td class="patent-data-table-td patent-date-value">Dec 17, 2013</td><td class="patent-data-table-td ">Hydradx, Inc.</td><td class="patent-data-table-td ">Diagnostic device and method for sensing hydration state of a mammalian subject</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8647890">US8647890</a></td><td class="patent-data-table-td patent-date-value">Feb 8, 2010</td><td class="patent-data-table-td patent-date-value">Feb 11, 2014</td><td class="patent-data-table-td ">Rapid Pathogen Screening, Inc.</td><td class="patent-data-table-td ">Method for the rapid diagnosis of targets in human body fluids using undiluted samples</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8672857">US8672857</a></td><td class="patent-data-table-td patent-date-value">Aug 25, 2010</td><td class="patent-data-table-td patent-date-value">Mar 18, 2014</td><td class="patent-data-table-td ">Bg Medicine, Inc.</td><td class="patent-data-table-td ">Galectin-3 and cardiac resynchronization therapy</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8697374">US8697374</a></td><td class="patent-data-table-td patent-date-value">Feb 25, 2009</td><td class="patent-data-table-td patent-date-value">Apr 15, 2014</td><td class="patent-data-table-td ">3M Innovative Properties Company</td><td class="patent-data-table-td ">Antibodies to Clostridium difficile spores and uses thereof</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8722426">US8722426</a></td><td class="patent-data-table-td patent-date-value">Mar 5, 2010</td><td class="patent-data-table-td patent-date-value">May 13, 2014</td><td class="patent-data-table-td ">Quidel Corporation</td><td class="patent-data-table-td ">Devices for the detection of multiple analytes in a sample</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8734341">US8734341</a></td><td class="patent-data-table-td patent-date-value">Nov 2, 2006</td><td class="patent-data-table-td patent-date-value">May 27, 2014</td><td class="patent-data-table-td ">Ipventure, Inc.</td><td class="patent-data-table-td ">Method and apparatus to sense hydration level of a person</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US20110124127">US20110124127</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Nov 10, 2008</td><td class="patent-data-table-td patent-date-value">May 26, 2011</td><td class="patent-data-table-td ">Robert Nigel Caterer</td><td class="patent-data-table-td ">Methods of quantification for lateral flow devices</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US20130330760">US20130330760</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Feb 7, 2012</td><td class="patent-data-table-td patent-date-value">Dec 12, 2013</td><td class="patent-data-table-td ">University Of Florida Research Foundation</td><td class="patent-data-table-td ">Compositions and methods for monitoring oxalate</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/DE102011086568A1?cl=en">DE102011086568A1</a></td><td class="patent-data-table-td patent-date-value">Nov 17, 2011</td><td class="patent-data-table-td patent-date-value">May 24, 2012</td><td class="patent-data-table-td ">fzmb GmbH, Forschungszentrum für Medizintechnik und Biotechnologie</td><td class="patent-data-table-td ">Amplifying signals in heterogeneous binding assays based on donor or receptor complex, comprises adding particle of first particle class and particle of second particle class to donor or receptor complex and optionally repeating steps</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP2487490A1?cl=en">EP2487490A1</a></td><td class="patent-data-table-td patent-date-value">Feb 11, 2011</td><td class="patent-data-table-td patent-date-value">Aug 15, 2012</td><td class="patent-data-table-td ">FZMB GmbH Forschungszentrum für Medizintechnik und Biotechnologie</td><td class="patent-data-table-td ">Heterogeneous binding assays with improved optical ability to be evaluated or porous fixed phase for same</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP2592418A1?cl=en">EP2592418A1</a></td><td class="patent-data-table-td patent-date-value">Feb 29, 2008</td><td class="patent-data-table-td patent-date-value">May 15, 2013</td><td class="patent-data-table-td ">Church &amp; Dwight Co., Inc.</td><td class="patent-data-table-td ">Diagnostic detecting device</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP2716656A1?cl=en">EP2716656A1</a></td><td class="patent-data-table-td patent-date-value">Jun 16, 2008</td><td class="patent-data-table-td patent-date-value">Apr 9, 2014</td><td class="patent-data-table-td ">Xiamen University</td><td class="patent-data-table-td ">Monoclonal antibodies binding to avian influenza virus subtype H5 haemagglutinin and uses thereof</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO2003050503A2?cl=en">WO2003050503A2</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Dec 10, 2002</td><td class="patent-data-table-td patent-date-value">Jun 19, 2003</td><td class="patent-data-table-td ">Rett Corp</td><td class="patent-data-table-td ">Multiple binding moiety chromatography device, methods of using and methods of making same</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO2008106650A2?cl=en">WO2008106650A2</a></td><td class="patent-data-table-td patent-date-value">Feb 29, 2008</td><td class="patent-data-table-td patent-date-value">Sep 4, 2008</td><td class="patent-data-table-td ">Church &amp; Dwight Co Inc</td><td class="patent-data-table-td ">Diagnostic detection device</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO2008154813A1?cl=en">WO2008154813A1</a></td><td class="patent-data-table-td patent-date-value">Jun 16, 2008</td><td class="patent-data-table-td patent-date-value">Dec 24, 2008</td><td class="patent-data-table-td ">Univ Xiamen</td><td class="patent-data-table-td ">Monoclonal antibodies binding to avian influenza virus subtype h5 haemagglutinin and uses thereof</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO2010007432A2?cl=en">WO2010007432A2</a></td><td class="patent-data-table-td patent-date-value">Jul 15, 2009</td><td class="patent-data-table-td patent-date-value">Jan 21, 2010</td><td class="patent-data-table-td ">L3 Technology Limited</td><td class="patent-data-table-td ">Assay device and methods</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO2010078411A1?cl=en">WO2010078411A1</a></td><td class="patent-data-table-td patent-date-value">Dec 30, 2009</td><td class="patent-data-table-td patent-date-value">Jul 8, 2010</td><td class="patent-data-table-td ">Children&#39;s Medical Center Corporation</td><td class="patent-data-table-td ">Method of predicting acute appendicitis</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO2012003475A1?cl=en">WO2012003475A1</a></td><td class="patent-data-table-td patent-date-value">Jul 1, 2011</td><td class="patent-data-table-td patent-date-value">Jan 5, 2012</td><td class="patent-data-table-td ">Bg Medicine, Inc.</td><td class="patent-data-table-td ">Statin therapy monitored by galectin- 3 measurement</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO2012040434A2?cl=en">WO2012040434A2</a></td><td class="patent-data-table-td patent-date-value">Sep 22, 2011</td><td class="patent-data-table-td patent-date-value">Mar 29, 2012</td><td class="patent-data-table-td ">Eci Biotech, Inc.</td><td class="patent-data-table-td ">Ultrasensitive detection of beta hemolytic streptococcus</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO2012099897A1?cl=en">WO2012099897A1</a></td><td class="patent-data-table-td patent-date-value">Jan 17, 2012</td><td class="patent-data-table-td patent-date-value">Jul 26, 2012</td><td class="patent-data-table-td ">Symbolics, Llc</td><td class="patent-data-table-td ">Lateral flow assays using two dimensional features</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO2012106341A1?cl=en">WO2012106341A1</a></td><td class="patent-data-table-td patent-date-value">Jan 31, 2012</td><td class="patent-data-table-td patent-date-value">Aug 9, 2012</td><td class="patent-data-table-td ">Bg Medicine, Inc.</td><td class="patent-data-table-td ">Use of galectin-3 for detecting and prognosing heart failure after acute coronary syndrome</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO2012162531A1?cl=en">WO2012162531A1</a></td><td class="patent-data-table-td patent-date-value">May 24, 2012</td><td class="patent-data-table-td patent-date-value">Nov 29, 2012</td><td class="patent-data-table-td ">Bg Medicine, Inc.</td><td class="patent-data-table-td ">Inhibitors of galectin-3 and methods of use thereof</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO2013103984A2?cl=en">WO2013103984A2</a></td><td class="patent-data-table-td patent-date-value">Jan 7, 2013</td><td class="patent-data-table-td patent-date-value">Jul 11, 2013</td><td class="patent-data-table-td ">Bg Medicine, Inc.</td><td class="patent-data-table-td ">Use of galectin-3 for risk assessment and detection of preeclampsia and related conditions</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO2013137508A1?cl=en">WO2013137508A1</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Mar 21, 2012</td><td class="patent-data-table-td patent-date-value">Sep 19, 2013</td><td class="patent-data-table-td ">(주) 나비바이오텍</td><td class="patent-data-table-td ">Diagnostic apparatus for colored particle immunoassay, and diagnostic method thereof</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO2014012077A1?cl=en">WO2014012077A1</a></td><td class="patent-data-table-td patent-date-value">Jul 12, 2013</td><td class="patent-data-table-td patent-date-value">Jan 16, 2014</td><td class="patent-data-table-td ">Genisphere, Llc</td><td class="patent-data-table-td ">Lateral flow assays using dna dendrimers</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO2014015076A1?cl=en">WO2014015076A1</a></td><td class="patent-data-table-td patent-date-value">Jul 17, 2013</td><td class="patent-data-table-td patent-date-value">Jan 23, 2014</td><td class="patent-data-table-td ">Symbolics, Llc</td><td class="patent-data-table-td ">Lateral flow assays using two dimensional features</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO2014043247A1?cl=en">WO2014043247A1</a></td><td class="patent-data-table-td patent-date-value">Sep 11, 2013</td><td class="patent-data-table-td patent-date-value">Mar 20, 2014</td><td class="patent-data-table-td ">Force Diagnostics, Inc</td><td class="patent-data-table-td ">Rapid tests for insurance underwriting</td></tr></table><div class="patent-section-footer">* Cited by examiner</div></div><div class="patent-section patent-tabular-section"><a id="classifications"></a><div class="patent-section-header"><span class="patent-section-title">Classifications</span></div><table class="patent-data-table"><thead class="patent-data-table-thead"><tr class="patent-data-table"><th class="patent-data-table-th"> </th><th class="patent-data-table-th"> </th></tr></thead><tr><td class="patent-data-table-td ">U.S. Classification</td><td class="patent-data-table-td "><span class="nested-value"><a href="http://www.google.com/url?id=mHNdBAABERAJ&q=http://www.uspto.gov/web/patents/classification/uspc436/defs436.htm&usg=AFQjCNGx2wdEO-lMZYH5-JBwc-X_dDDKIg#C436S514000">436/514</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=mHNdBAABERAJ&q=http://www.uspto.gov/web/patents/classification/uspc436/defs436.htm&usg=AFQjCNGx2wdEO-lMZYH5-JBwc-X_dDDKIg#C436S523000">436/523</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=mHNdBAABERAJ&q=http://www.uspto.gov/web/patents/classification/uspc436/defs436.htm&usg=AFQjCNGx2wdEO-lMZYH5-JBwc-X_dDDKIg#C436S169000">436/169</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=mHNdBAABERAJ&q=http://www.uspto.gov/web/patents/classification/uspc436/defs436.htm&usg=AFQjCNGx2wdEO-lMZYH5-JBwc-X_dDDKIg#C436S533000">436/533</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=mHNdBAABERAJ&q=http://www.uspto.gov/web/patents/classification/uspc436/defs436.htm&usg=AFQjCNGx2wdEO-lMZYH5-JBwc-X_dDDKIg#C436S817000">436/817</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=mHNdBAABERAJ&q=http://www.uspto.gov/web/patents/classification/uspc436/defs436.htm&usg=AFQjCNGx2wdEO-lMZYH5-JBwc-X_dDDKIg#C436S544000">436/544</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=mHNdBAABERAJ&q=http://www.uspto.gov/web/patents/classification/uspc436/defs436.htm&usg=AFQjCNGx2wdEO-lMZYH5-JBwc-X_dDDKIg#C436S518000">436/518</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=mHNdBAABERAJ&q=http://www.uspto.gov/web/patents/classification/uspc435/defs435.htm&usg=AFQjCNFivWgFr8pvtdk7qYLW9R7yxFP7Dg#C435S176000">435/176</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=mHNdBAABERAJ&q=http://www.uspto.gov/web/patents/classification/uspc436/defs436.htm&usg=AFQjCNGx2wdEO-lMZYH5-JBwc-X_dDDKIg#C436S818000">436/818</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=mHNdBAABERAJ&q=http://www.uspto.gov/web/patents/classification/uspc436/defs436.htm&usg=AFQjCNGx2wdEO-lMZYH5-JBwc-X_dDDKIg#C436S524000">436/524</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=mHNdBAABERAJ&q=http://www.uspto.gov/web/patents/classification/uspc435/defs435.htm&usg=AFQjCNFivWgFr8pvtdk7qYLW9R7yxFP7Dg#C435S007920">435/7.92</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=mHNdBAABERAJ&q=http://www.uspto.gov/web/patents/classification/uspc435/defs435.htm&usg=AFQjCNFivWgFr8pvtdk7qYLW9R7yxFP7Dg#C435S970000">435/970</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=mHNdBAABERAJ&q=http://www.uspto.gov/web/patents/classification/uspc436/defs436.htm&usg=AFQjCNGx2wdEO-lMZYH5-JBwc-X_dDDKIg#C436S810000">436/810</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=mHNdBAABERAJ&q=http://www.uspto.gov/web/patents/classification/uspc436/defs436.htm&usg=AFQjCNGx2wdEO-lMZYH5-JBwc-X_dDDKIg#C436S178000">436/178</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=mHNdBAABERAJ&q=http://www.uspto.gov/web/patents/classification/uspc436/defs436.htm&usg=AFQjCNGx2wdEO-lMZYH5-JBwc-X_dDDKIg#C436S814000">436/814</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=mHNdBAABERAJ&q=http://www.uspto.gov/web/patents/classification/uspc436/defs436.htm&usg=AFQjCNGx2wdEO-lMZYH5-JBwc-X_dDDKIg#C436S525000">436/525</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=mHNdBAABERAJ&q=http://www.uspto.gov/web/patents/classification/uspc427/defs427.htm&usg=AFQjCNF3FM72q9xAgbSulaRyuhn4n5trIA#C427S002110">427/2.11</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=mHNdBAABERAJ&q=http://www.uspto.gov/web/patents/classification/uspc422/defs422.htm&usg=AFQjCNHXLT_uXJvUp9ERMJkh6x6moeyOWg#C422S417000">422/417</a></span></td></tr><tr><td class="patent-data-table-td ">International Classification</td><td class="patent-data-table-td "><span class="nested-value"><a href="http://www.google.com/url?id=mHNdBAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=B01L0003000000">B01L3/00</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=mHNdBAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=G01N0033530000">G01N33/53</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=mHNdBAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=G01N0033740000">G01N33/74</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=mHNdBAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=G01N0033760000">G01N33/76</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=mHNdBAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=G01N0033543000">G01N33/543</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=mHNdBAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=G01N0037000000">G01N37/00</a></span></td></tr><tr><td class="patent-data-table-td ">Cooperative Classification</td><td class="patent-data-table-td "><span class="nested-value"><a href="http://www.google.com/url?id=mHNdBAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=Y10S436/818">Y10S436/818</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=mHNdBAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=Y10S435/805">Y10S435/805</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=mHNdBAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=Y10S436/817">Y10S436/817</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=mHNdBAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=Y10S435/97">Y10S435/97</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=mHNdBAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=Y10S436/814">Y10S436/814</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=mHNdBAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=Y10S435/81">Y10S435/81</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=mHNdBAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=Y10S436/81">Y10S436/81</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=mHNdBAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=G01N33/76">G01N33/76</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=mHNdBAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=G01N33/54366">G01N33/54366</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=mHNdBAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=B01L2300/0681">B01L2300/0681</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=mHNdBAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=B01L3/5023">B01L3/5023</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=mHNdBAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=B01L2300/0825">B01L2300/0825</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=mHNdBAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=G01N33/743">G01N33/743</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=mHNdBAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=G01N33/54313">G01N33/54313</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=mHNdBAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=B01L2400/0406">B01L2400/0406</a></span></td></tr><tr><td class="patent-data-table-td ">European Classification</td><td class="patent-data-table-td "><span class="nested-value">B01L3/5023</span>, <span class="nested-value">G01N33/543K</span>, <span class="nested-value">G01N33/76</span>, <span class="nested-value">G01N33/74B</span>, <span class="nested-value">G01N33/543D</span></td></tr></table><div class="patent-section-footer"></div></div><div class="patent-section patent-tabular-section"><a id="legal-events"></a><div class="patent-section-header"><span class="patent-section-title">Legal Events</span></div><table class="patent-data-table"><thead class="patent-data-table-thead"><tr class="patent-data-table"><th class="patent-data-table-th">Date</th><th class="patent-data-table-th">Code</th><th class="patent-data-table-th">Event</th><th class="patent-data-table-th">Description</th></tr></thead><tr><td class="patent-data-table-td patent-date-value">Apr 30, 2014</td><td class="patent-data-table-td ">FPAY</td><td class="patent-data-table-td ">Fee payment</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Year of fee payment: </span><span class="nested-value">12</span></div></td></tr><tr><td class="patent-data-table-td patent-date-value">May 26, 2010</td><td class="patent-data-table-td ">FPAY</td><td class="patent-data-table-td ">Fee payment</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Year of fee payment: </span><span class="nested-value">8</span></div></td></tr><tr><td class="patent-data-table-td patent-date-value">Jan 29, 2008</td><td class="patent-data-table-td ">B1</td><td class="patent-data-table-td ">Reexamination certificate first reexamination</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Free format text: </span><span class="nested-value">CLAIMS 1-4, 6, 18, 20, 24-25 AND 37 ARE CANCELLED. CLAIMS 5, 7-8, 19, 21-23, 35-36 AND 38 ARE DETERMINED TO BE PATENTABLE AS AMENDED. CLAIMS 9-17 AND 26-34, DEPENDENT ON AN AMENDED CLAIM, ARE DETERMINED TO BE PATENTABLE. NEW CLAIMS 39-42 ARE ADDED AND DETERMINED TO BE PATENTABLE.</span></div></td></tr><tr><td class="patent-data-table-td patent-date-value">May 26, 2006</td><td class="patent-data-table-td ">FPAY</td><td class="patent-data-table-td ">Fee payment</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Year of fee payment: </span><span class="nested-value">4</span></div></td></tr><tr><td class="patent-data-table-td patent-date-value">Dec 13, 2005</td><td class="patent-data-table-td ">RR</td><td class="patent-data-table-td ">Request for reexamination filed</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Effective date: </span><span class="nested-value">20050915</span></div></td></tr><tr><td class="patent-data-table-td patent-date-value">Aug 3, 2004</td><td class="patent-data-table-td ">AS</td><td class="patent-data-table-td ">Assignment</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Owner name: </span><span class="nested-value">CHURCH &amp; DWIGHT CO., INC., NEW JERSEY</span></div><div class="nested-key-value"><span class="nested-key">Free format text: </span><span class="nested-value">MERGER;ASSIGNOR:ARMKEL LLC;REEL/FRAME:014934/0603</span></div><div class="nested-key-value"><span class="nested-key">Effective date: </span><span class="nested-value">20040528</span></div><div class="nested-key-value"><span class="nested-key">Owner name: </span><span class="nested-value">CHURCH &amp; DWIGHT CO., INC. 469 NORTH HARRISON STREE</span></div><div class="nested-key-value"><span class="nested-key">Free format text: </span><span class="nested-value">MERGER;ASSIGNOR:ARMKEL LLC /AR;REEL/FRAME:014934/0603</span></div></td></tr><tr><td class="patent-data-table-td patent-date-value">Oct 1, 2002</td><td class="patent-data-table-td ">AS</td><td class="patent-data-table-td ">Assignment</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Owner name: </span><span class="nested-value">MEDPOINTE HEALTHCARE, INC., NEW JERSEY</span></div><div class="nested-key-value"><span class="nested-key">Free format text: </span><span class="nested-value">LICENSE;ASSIGNOR:ARMKEL, LLC;REEL/FRAME:013343/0236</span></div><div class="nested-key-value"><span class="nested-key">Effective date: </span><span class="nested-value">20020607</span></div></td></tr><tr><td class="patent-data-table-td patent-date-value">Jul 30, 2002</td><td class="patent-data-table-td ">AS</td><td class="patent-data-table-td ">Assignment</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Owner name: </span><span class="nested-value">ARMKEL LLC, NEW JERSEY</span></div><div class="nested-key-value"><span class="nested-key">Free format text: </span><span class="nested-value">ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:MEDPOINTE HEALTHCARE, INC.(F/K/A CARTER-WALLACE, INC.);REEL/FRAME:013392/0654</span></div><div class="nested-key-value"><span class="nested-key">Effective date: </span><span class="nested-value">20020607</span></div><div class="nested-key-value"><span class="nested-key">Owner name: </span><span class="nested-value">ARMKEL LLC 469 NORTH HARRISON STREET PRINCETON NEW</span></div><div class="nested-key-value"><span class="nested-key">Owner name: </span><span class="nested-value">ARMKEL LLC 469 NORTH HARRISON STREETPRINCETON, NEW</span></div><div class="nested-key-value"><span class="nested-key">Free format text: </span><span class="nested-value">ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:MEDPOINTE HEALTHCARE, INC.(F/K/A CARTER-WALLACE, INC.) /AR;REEL/FRAME:013392/0654</span></div></td></tr></table><div class="patent-section-footer"></div></div><div class="modal-dialog" id="patent-images-lightbox"><div class="patent-lightbox-controls"><div class="patent-lightbox-rotate-controls"><div class="patent-lightbox-rotation-text">Rotate</div><div class="rotate-icon rotate-ccw-icon"></div><div class="rotate-icon rotate-cw-icon"></div></div><div class="patent-lightbox-index-counter"></div><a class="patent-lightbox-fullsize-link" target="_blank">Original Image</a><div class="patent-drawings-control patent-drawings-next"><img class="patent-drawings-button-img"src="/googlebooks/images/kennedy/page_right.png" alt="Next page"width="21" height="21" /></div><div class="patent-drawings-control patent-drawings-prev"><img class="patent-drawings-button-img"src="/googlebooks/images/kennedy/page_left.png" alt="Previous page"width="21" height="21" /></div></div><div class="modal-dialog-content"><div class="patent-lightbox-image-holder"><div class="patent-lightbox-placeholder"></div></div></div></div><script>_OC_initPatentsAtb({image_not_available_html: " Image not available"});</script></div></div></div></td></tr></table><script>(function() {var href = window.location.href;if (href.indexOf('?') !== -1) {var parameters = href.split('?')[1].split('&');for (var i = 0; i < parameters.length; i++) {var param = parameters[i].split('=');if (param[0] == 'focus') {var elem = document.getElementById(param[1]);if (elem) {elem.focus();}}}}})();</script><script>_OC_addFlags({LockSrc:"/books/javascript/lock_8a2b04e7bf975d5171d8e4c0b6365c7a.js", Host:"http://www.google.com/", IsBooksRentalEnabled:1, IsWebstoreDisplayCaseEnabled:1, IsObfuscationEnabled:1, IsBrowsingHistoryEnabled:1, IsWebReaderSvgEnabled:0, IsGeoLayerEnabled:1, IsImageModeNotesEnabled:1, IsCopyMenuItemEnabled:1, IsGiftingEnabled:0, IsWebReaderUniversalPaginatorEnabled:0, IsOfflineBubbleEnabled:1, IsReaderEnabledForPlayRequests:1, IsFutureOnSaleVolumesEnabled:1, IsOfflineRestrictedCopyEnabled:1, IsBooksUnifiedLeftNavEnabled:1, IsRestrictedCopyEnabled:1, IsZipitFolderCollectionEnabled:1, IsEndOfSampleRecommendationsEnabled:1, IsRatingsOnBookcardsEnabled:1, IsAdsDisabled:0, IsIframePageDisplayEnabled:0, IsEmbeddedMediaEnabled:1, IsImageModeAnnotationsEnabled:1, IsMyLibraryGooglePlusEnabled:1, IsImagePageProviderEnabled:0, IsBookcardListPriceSmall:0, IsInternalUser:0, IsBooksShareButtonEnabled:0, IsPreOrdersEnabled:0, IsDisabledRandomBookshelves:0, WebstoreDisplayCasePosition:3});_OC_Run({"enable_p13n":false,"add_vol_to_collection_base_url":"http://www.google.com/patents?op=add\u0026sig=ACfU3U0zfVB2Qrsf34OR2hI21w5L_hwusQ\u0026id=mHNdBAABERAJ","remove_vol_from_collection_base_url":"http://www.google.com/patents?op=remove\u0026sig=ACfU3U1P9M-CFo72RETUzvgp65NyE6kyWw\u0026id=mHNdBAABERAJ","logged_in":false,"p13n_save_user_settings_url":"http://www.google.com/patents?op=edit_user_settings\u0026sig=ACfU3U30mIORUycPgl3pb9zpStINe2S7zg","is_cobrand":false,"sign_in_url":"https://www.google.com/accounts/Login?service=\u0026continue=http://www.google.com/patents%3Fhl%3Den\u0026hl=en","is_play_enabled":true}, {"volume_id":"","is_ebook":true,"volumeresult":{"has_flowing_text":false,"has_scanned_text":true,"can_download_pdf":false,"can_download_epub":false,"is_pdf_drm_enabled":false,"is_epub_drm_enabled":false,"download_pdf_url":"http://www.google.com/patents/download/Test_device_and_method_for_colored_parti.pdf?id=mHNdBAABERAJ\u0026output=pdf\u0026sig=ACfU3U3NJ4-uv_xsN1ZMPlX5QNfDzEl1aw"},"sample_url":"http://www.google.com/patents/reader?id=mHNdBAABERAJ\u0026printsec=frontcover\u0026output=reader\u0026source=gbs_atb_hover","is_browsable":true,"is_public_domain":true}, {});</script><div id="footer_table" style="font-size:83%;text-align:center;position:relative;top:20px;height:4.5em;margin-top:2em"><div style="margin-bottom:8px"><a href=http://www.google.com/><nobr>Google&nbsp;Home</nobr></a> - <a href=//www.google.com/patents/sitemap/><nobr>Sitemap</nobr></a> - <a href=http://www.google.com/googlebooks/uspto.html><nobr>USPTO Bulk Downloads</nobr></a> - <a href=/intl/en/privacy/><nobr>Privacy Policy</nobr></a> - <a href=/intl/en/policies/terms/><nobr>Terms of Service</nobr></a> - <a href=https://support.google.com/faqs/answer/2539193?hl=en><nobr>About Google Patents</nobr></a> - <a href="http://www.google.com/tools/feedback/intl/en/error.html" onclick="try{_OC_startFeedback({productId: '72792',locale: 'en'});return false;}catch(e){}"><nobr>Send Feedback</nobr></a></div><span>Data provided by IFI CLAIMS Patent Services</span><br><span >&copy;2012 Google</span></div> <script type="text/javascript">var gaJsHost = (("https:" == document.location.protocol) ? "https://ssl." : "http://www.");document.write(unescape("%3Cscript src='" + gaJsHost + "google-analytics.com/ga.js' type='text/javascript'%3E%3C/script%3E"));</script><script type="text/javascript">var pageTracker = _gat._getTracker("UA-27188110-1");pageTracker._setCookiePath("/patents/");pageTracker._trackPageview();</script> </body></html>